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ABSTRACT
THE TANDEM ZINC-MEDIATED CHAIN EXTENSION-IODOMETHYLATION
REACTION AND ITS APPLICATIONS
By
QINGLIN PU 
University of New Hampshire, September, 2007
A tandem zinc-mediated chain extension-iodomethylation reaction was developed 
and used to generate various a-iodomethyl y-keto esters, amides and imides. The yields 
for formation of a-iodomethyl y-keto esters were higher than a-iodomethyl y-keto amides. 
P-Keto amides with bulky substituents on the amide bond were not good substrates for 
the zinc-mediated chain extension-iodomethylation reaction. Use o f a chiral P-keto imide 
provided a facile means to effectively control the stereochemistry at the a-position o f the 
extended chain with this methodology.
A palladium-catalyzed cross-coupling reaction was used to install different 
functional groups at the a-carbon site o f an a-iodomethyl y-keto ester and imide. 
Reactions between a-iodomethylated y-keto compounds and aromatic iodides or an 
alkenyl bromide were performed successfully in modest yields. However, iodophenol and 
1 -fluoro-4-iodobenzene did not provide products when reacted with the a-iodomethylated 
product under the same reaction conditions.
XV
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Other applications o f the a-iodomethyl y-keto ester were studied in an effort to 
attach different alkyl groups to the a-position, including thiolation and nucleophilic 
alkylation.
The a-substituted y-keto esters or imides can be designed to contain functionality 
that mimics the side chain of amino acids in a ketomethylene peptide isostere.
xvi




Chain extension methodology provides opportunities for organic chemists to 
lengthen existing carbon chains to a desired chain length. The versatility o f chain 
extension reactions have been shown in the preparation o f a variety o f building blocks for 
bioorganic chemistry research. The generation o f 1,4-dicarbonyl compounds is o f great 
interest in these research fields. Most common methods o f chain extension leading to the 
1,4-dicarbonyl functionality involve the intermediacy o f a donor-acceptor cyclopropane, 
which is defined by an electron donating group (alkoxyl or amino) and an electron 
withdrawing group (ester, amide, phosphonate, imide, etc) being present on two adjacent 
carbons of a cyclopropane ring. A number o f different ways to form 1,4-dicarbonyl 
compounds, especially y-keto esters via donor-acceptor cyclopropane, have been reported. 
A brief review o f the various chain extension reactions is described below.
Bieraugel’s Method
Bieraugel and coworkers1 reported the first chain extension method used to convert 
P-keto esters 1 to y-keto esters 5 in 1974. As a result o f the reaction between a P-keto 
ester and a secondary amine, an enamine ester 2 was formed. When the Simmons- Smith 
reagent was added to the enamine, 2-aminocyclopropane ester 3 was generated. This 
donor-acceptor cyclopropane was believed to be the intermediate preceding formation of 
the ring-opened species imine 4 in this reaction. A y-keto ester was
1
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produced after hydrolysis o f the imine intermediate (Scheme 1). Although low yields in 
the conversion o f various P-keto esters led to limited applications for this method, 
Bieraugel’s strategy was the first method reported to pursue chain extension reaction with 
a donor-acceptor cyclopropane.
R
n h r 2 .



















Scheme 1. Bieraugel’s Method for Formation o f y-Keto Esters 5
Saigo’s Method
Saigo and coworkers modified Bieraugel’s method through the formation of a 
trimethylsilyl (TMS) enol ether 6, and applied this strategy to a series of p-keto esters and 
P-diketones (Scheme 2).3 When the TMS enol ether was trapped with the Simmons- 
Smith reagent, two different TMS protected cyclopropyl alcohol intermediates 8 and 10 
appeared to have been formed in the process o f the reaction. Multiple additions of the 
methylene groups took place and the formation o f an unexpected mixture of carboxylic 
acids 11 and 12 were isolated after saponification. No unsubstituted y-keto ester was
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
























Scheme 2. Saigo’s Method for Formation o f y-Keto Acids 11 and 12
Dowd’s Method
Dowd and coworkers developed a different strategy for the formation o f y-keto 
esters from substituted P-keto esters in which a free radical-mediated ring expansion 
reaction was involved (Scheme 3).4 The substituted P-keto ester starting material 13, 
which was prepared by addition o f an a-substituted P-keto ester with methylene 
dibromide, was treated with tri-n-butyltin hydride in the presence o f AIBN to generate a 
radical intermediate 14. This radical species was proposed to attack the adjacent carbonyl
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
group to form a donor-acceptor cyclopropanoxy radical 15, followed by fragmentation to 
generate an ester stabilized radical 16. Capture o f a hydrogen atom from tri-n-butyltin 
hydride completed the formation o f the product and continued the radical chain reaction.
Dowd’s method has been shown to provide access to a variety o f chain extended or 
ring-expanded products, especially for the formation o f five to eight-membered rings.4 
The targeted compound was always an a-substituted y-keto ester, for this methodology 
was not applicable to a-unsubstituted P-keto esters. The most likely explanation is that 
competing E2 reactions would take place through the removal of an acidic proton on the 
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Scheme 3. Dowd’s Method for Formation of y-Keto Esters 17
4
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Reissig’s Method
Reissig’s research group developed a [2+l]-cycloaddition strategy in which a 
carbenoid derived from methyl diazoacetate in the presence o f copper (II) acetylacetonate 
was trapped with a silyl enol ether 18 to generate a cyclopropane intermediate 19.5 
Fluoride promoted the fragmentation o f the cyclopropane ring and offered the y-keto 
ester 5. Although a different starting material, which was derived from a ketone species 
rather than P-keto ester, was used in this method, the common donor-acceptor 
cyclopropane was involved in the formation o f the y-keto ester. This was a 
complementary chain extension reaction to previous methods.
OR'









1) A= C 0 2 R', B=H
2) A= H, B= C 0 2 R'
Scheme 4. Reissig’s Method for Formation of y-Keto Ester 5
Zinc-carbenoid-mediated Chain Extension
A zinc-mediated chain extension methodology has been developed by Zercher’s 
research group. The chain extension reaction utilizes Furukawa-modified Simmons- 
Smith cyclopropanation conditions for the preparation of y-keto esters from a- 
unsubstituted p-keto esters.6 The proposed mechanism of this zinc-mediated chain
5
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extension is believed to involve formation o f a donor-acceptor cyclopropane (Scheme 5). 
Deprotonation o f the p-keto ester by diethyl zinc or the zinc carbenoid 
(ethyl(iodomethyl)zinc) derived from Et2Zn and CH2I2 results in the formation o f the zinc 
enolate 20, which has been confirmed as an intermediate by NMR studies and production 
o f ethane gas as a byproduct o f enolate formation.7 Direct alkylation o f the zinc enolate 
with the carbenoid EtZnCfEI could provide the zinc intermediate 21. The cyclopropyl 
alkoxide intermediate 22 is assumed to be generated through an intramolecular 
cyclization, but no direct evidence supports the presence o f this cyclopropane 
intermediate, possibly due to its rapid fragmentation to an oligomeric zinc species 23, 
which bears structural and reactivity similarity to a Reformatsky intermediate. Quenching 
with an acid, such as aqueous ammonium chloride solution produced an a-unsubstituted 
y-keto ester 5. This one-pot method is more efficient and is easier to perform than the 
previously reported chain extension methods, which usually involved multi-step 
sequences. The efficiency o f the zinc-mediated chain extension reaction is unaffected by 
the presence o f olefin functionality.6
6























Scheme 5. Mechanism of the Zinc-mediated Chain Extension Reaction
This zinc-mediated chain extension reaction has been successfully applied to a 
variety o f functionalities such as P-keto amides 25, phosphonates 278 and imides 29 
(Scheme 6).7 These substrates work with the zinc carbenoid in a similar pattern compared 
to P-keto esters. Although the zinc carbenoid method works inefficiently with a- 
substituted P-keto dicarbonyl substrates, tandem zinc-mediated chain extension reactions 
provide attractive approaches to target the desired a-substituted y-keto compounds.
7
























Scheme 6. Chain Extension o f P-Keto Amides, Phosphonates and Imides
Recently Xue and his coworkers reported a modified zinc-mediated chain extension 
reaction for the generation o f a-unsubstituted 1,4-diketones 32 from a-unsubstituted 1,3- 
diketones 31 by using a different organozinc carbenoid (CFsCC^ZnCEkl).9 This 
carbenoid was prepared by treatment o f the original carbenoid (EtZnCFkl) with 
trifluoroacetic acid (Scheme 7). The proposed mechanism by Xue and coworkers, which 
still involved in generation of the cyclopropane intermediate, was based on analogy to 
Zercher’s proposed mechanism. Both aromatic and aliphatic 1,3-diketones were 
employed to give corresponding 1,4-diketone products in moderate yields. No desired 
compounds were observed in the reactions o f a-substituted P-diketones and excess
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
amount o f zinc carbenoid resulted in formation o f 1,2-disubstituted cyclopropyl alcohols. 
This carbenoid has also been applied to the ring expansion of P-keto lactones.98
a)CF3 C 0 2ZnCH2I
31 32
Scheme 7. Xue’s Chain Extension Reaction for the Formation o f 1,4-Diketones 32
Tandem Chain Extension Methylation Reaction
Based upon the practical limitation of zinc-mediated chain extension in the direct 
formation of a-substituted y-keto esters and amides from a-substituted P-keto esters, 
Zercher and Hilgenkamp reported a variation on the chain extension reaction that 
provided a useful solution to this limitation.7,10 This approach was utilized to produce a- 
methylated y-keto esters and amides in modest yields. In order to facilitate methylation, 
trimethylsilylchloride (TMSC1) was added prior to quenching the reaction mixture 
(Scheme 8). The trimethysilyl group appeared to aid fragmentation o f the proposed 
dimeric species and formation o f an activated intermediate, which could be TMS-ketene 
acetal species 33 or trimethylsilyloxycyclopropane 34. Either intermediate could act as a 
nucleophile and attack the electrophilic carbenoid, which was present in excess in the 
reaction, and provide a zinc homoenolate intermediate 35. When quenched with an acid, 
the a-methyl y-keto esters 36 were obtained.
9






















Scheme 8. Proposed Mechanism of Chain Extension Methylation Reaction
In an effort to test the efficiency o f the tandem chain extension a-methylation 
reaction, several P-keto esters or amides were exposed to the reaction conditions. The 
desired a-methylated y-keto esters and tertiary amides were obtained in yields ranging 
from 57% to 73% after column chromatography. The data suggests that the methylation 
reaction was not hindered by the existence o f a bulky substituent or aromatic ring on the 
ester or amide functionality.
Table 1. Preparation o f a-Methyl y-Keto Esters
Entry R R Yield (%)
1 c h 3 c h 3 63
2 c h 3 tBu * 73
3 c h 3 CH2Ph 57
4 c 6h 5 Et 70
10
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In contrast to the good yields o f a-methylated y-keto esters, secondary P-keto 
amides, such as A-cyclohexyl 3-oxo-butanamide 37, provided low yields o f the 
corresponding a-methylated y-keto amides 38 (Scheme 9). a-Unsubstituted y-keto 
amides 39 were the major products o f the reaction. A proposed explanation for these 
results, which was supported by deuterium labeling studies, is that the secondary P-keto 
amide proton partially quenches the dimeric zinc species before its conversion to TMS- 
ketene acetal species 33 or trimethylsilyloxycyclopropane 34.
O O
38 (14%)b) cat TMSC1
37
39 (48%)
Scheme 9. Synthesis of a Secondary a-Methyl y-Keto Amide 39
Tandem chemistry has been explored to expand the applications o f the zinc- 
mediated chain extension reactions. For example, trapping the intermediate zinc enolate 
24 with a halogen as an electrophile, followed by elimination with an amine base, 
provides an a,P-unsaturated y-keto ester 41.11 Chain extension-aldol reactions, which 
involve the reaction between the zinc enolate 24 and various aldehydes provide the 
predominant syn-aldol products 40, with stereoselectivity much greater than in the typical
11
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Scheme 10. Applications o f the Chain Extension Reaction
Introduction to Peptide Isosteric Replacements
Over the past two decades, the utility o f 1,4-dicarbonyl compounds as components 
o f novel bioactive agents such as peptide inhibitors has been explored.13, 14 Peptide 
mimetics can be designed to mimic or block the bioactivity o f natural peptides or 
enzymes. For example, peptide isosteres have been widely used as inhibitors o f aspartic 
acid proteases (such as renin15), cysteine proteases 16and serine proteases.17 The cleavage
ID
of a normal peptide bond is described briefly in Scheme 11. Peptide isosteres are 
generated when the amide bonds o f a peptide are replaced by other functional groups of 
similar size that are hydrolytically stable. In these cases peptide isosteres are capable of 
maintaining similar binding properties as the natural peptide, but are not easily 
enzymatically degraded.19 Therefore, design and synthesis of peptidomimetics are crucial 
components of bioorganic and medicinal chemistry research. A number o f functional
12
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groups have been used to mimic the structure o f peptide bonds, including ketomethylene 
46,20 hydroxyethylene 47,21 alkenes 4822 and difluoroketomethylene groups 4923 (Figure 
1).
hydrolysis 






OH + h 2n
o r 2
45
Scheme 11. Hydrolysis o f a Peptide Chain
13
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48 49
Figure 1. Isosteric Replacements o f Peptide Amino Bonds
Previous Methods for Preparing Ketomethylene Isosteres
The ketomethylene replacement has proven to be effective in inhibition o f a variety 
of enzymatic systems, such as HIV protease,24 arginine aminopeptidases, 25 angiotensin- 
converting enzyme (ACE),26 human rhino virus (HRV) 3C protease,27 and retroviral 
protease. This type o f isostere has been incorporated in synthetic drugs (i.e. 
Ruprintrivir),14 as well as being observed as a key functionality in naturally-ocurring 
protease inhibitors (i.e. Arphamenines).250 Many approaches to the generation of 
ketomethylene isosteres have been investigated, and a brief review on this area is 
provided below.
One common method reported for the formation o f ketomethylene isosteres 
involves reactions of a Grignard reagent 51 (Scheme 12).25a The Grignard reagent 
derived from a chiral propyl bromide 50 was reacted with an TV-protected protected amino 
acid derivative, normally amino aldehyde 52, to generate intermediate alcohol 53. 
Protection o f the secondary hydroxyl group by acetylation was followed by removal o f
14
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the benzyl ether by hydrogenolysis, which provided a primary alcohol. This alcohol was 
oxidized to the corresponding acid 55 using ruthenium chloride and coupled with other 
amino acid derivatives. Cleavage o f the acetyl group and further oxidation provided the 
protected ketomethylene-containing isostere 57. However, the oxidation process was 
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Scheme 12. Synthesis o f Ketomethylene Isosteres Using Grignard Reagents
Hoffman and his coworkers developed another synthetic approach to 
ketomethylene isosteres. The key step in this approach was the formation o f a y-keto ester 
through direct alkylation of a P-keto ester.29 The p-keto ester 59 was prepared by treating
15
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the lithium enolate o f /-butyl acetate with an activated derivative o f amino acid 58. 
Addition o f sodium hydride to the P-keto ester resulted in the formation of the enolate, 
which was exposed to ethyl bromoacetate. Alkylation of the P-keto ester provided the a- 
substituted y-keto ester. Cleavage o f the /-butyl ester and decarboxylation by treatment 
with trifluoroacetic acid (TFA) provided the y-keto ester 60. Hydrolysis with lithium 
hydroxide and coupling with proline methyl ester gave the ketomethylene-containing 
peptide chain 61 (Scheme 13).























Scheme 13. Synthesis of Ketomethylene Isosteres through Alkylation o f P-Keto Esters
Another similar strategy was illustrated by the same authors using scalemic 
alkylating agents 2-triflyloxy esters 63, which allowed the incorporation of the a- 
substitution.30 Since tert-butyl P-keto esters could be deprotected and decarboxylated 
easily under acidic conditions, the /-butyl esters were used in alkylation reactions to 
improve overall yields in this modified method. Alkylation of /-butyl P-keto esters 62
16
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with 2-triflyloxy esters 63 followed by treatment o f the crude alkylation product by TFA, 
followed by LiOH gave y-keto acids 66. The resulting y-keto acids were coupled to chiral 
a-methylbenzylamine 67 to provide peptide isosteres 68 (Scheme 14). This chiral 
alkylation methodology offered high enantioselectivities for preparation of a-alkylated y- 
keto esters and acids, however, the deficiency o f the suitable chiral alkylating reagents 
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Scheme 14. Synthesis o f Ketomethylene Isosteres Using Chiral Alkylating Reagents
Another synthetic approach to ketomethylene isosteres, which was reported by
•> |
Lygo and Rudd in 1995, involved the use of a P-keto sulfone intermediate. The Boc- 
protected amino acid ester derivative 69 was reacted with a dianion derived from 
methylphenylsulfone to generate the desired sulfone 70, which could undergo the 
reaction with bromoacetate derivatives 71 to provide P-keto sulfone intermediate 72.
17
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Direct reduction using samarium iodide (Sink) in a mixture o f THF and MeOH afforded 
the ketomethylene tripeptide isosteres 73 (Scheme 15). Although this short route allowed 
for formation of peptide isosteres that were related to HIV protease inhibitors, 
epimerization was still observed during the base-catalyzed coupling reaction.
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Scheme 15. Synthesis o f Ketomethylene Isosteres through a P-Keto Sulfone
As described above, generation o f ketomethylene-containing peptide mimics often 
requires lengthy and demanding synthetic sequences. Control o f stereochemistry o f the a- 
carbon side chain has also been shown to be a challenge in most o f these synthetic 
approaches. Recently Zercher and coworkers demonstrated a simple and efficient zinc 
carbenoid-mediated method that facilitates the conversion of P-keto esters to y-keto esters 
and allows for the potential incorporation of a-side chain functionality.32 JV-Protected 
amino acids 74 were subjected to a neutral C-acylation reaction through intermediate acyl 
imidazoles to provide the corresponding P-keto esters 75. The target y-keto esters 76 were
18
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formed in good yields via a zinc-mediated chain extension reaction. Cleavage of the 
benzyl ester by hydrogenolysis, followed by EDC coupling with the methyl ester o f 
phenylalanine yielded the tripeptide mimic 77 (Scheme 16) as a single diastereomer. No 
epimerization of amino acid stereocenters was observed by chiral HPLC study.
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Scheme 16. Synthesis o f Ketomethylene-containing Tripeptide Isosteres through Zinc-
mediated Chain Extension Reaction
Application o f tandem reaction processes, including tandem chain extension-aldol 
and chain extension-methylation reactions, has provided access to a-substituted 
ketomethylene isosteres. Through appropriate selection o f starting materials and 
subsequent manipulation o f the tandem reaction products, a-side chains that mimic 
natural amino acid side chains have been produced (Scheme 17).
19
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Scheme 17. Preparation of a a-Substituted y-Keto Imide 80 through Tandem Chain
Although many approaches have been used for the synthesis o f ketomethylene 
isosteric replacements, satisfactory results have not been obtained in all cases. The zinc 
carbenoid-mediated chain extension reaction provides an opportunity to synthesize 
ketomethylene isosteres via a novel synthetic route; however, efficient mimicry o f the 
peptide backbone requires a substituent, normally an alkyl group, at the a-carbon site. 
Furthermore, control of this a-stereocenter is essential to the efficient formation o f the 
isostere. The diversity o f side chains required in ketomethylene isosteres suggests that a 
variety of routes are required for the incorporation o f the side chain. Development o f an 
efficient methodology for the preparation o f ketomethylene isosteres o f peptide bonds 
that facilitates the stereocontrolled incorporation o f diverse side-chain functionality has 
become an urgent priority in this research area.
Extension-aldol Reaction
20




The utility o f the zinc-mediated chain extension reaction has expanded recently to
9^the preparation o f ketomethylene-containing peptide isosteric replacements. As 
expressed in chapter I, the zinc-mediated chain extension methylation reaction provides 
the ability to incorporate an a-methyl substituent in y-keto esters and amides through 
treatment o f the intermediate zinc enolate equivalent with excess carbenoid and catalytic 
TMS-C1.7’10 Since information gained from previous experimental data indicates that 
nucleophilic character is present in the zinc homoenolate, treatment with iodine provides 
the opportunity to generate a-iodomethyl y-keto esters 81 (or amides). The opportunity to 
perform subsequent chemistry leading to the formation of various a-substituted y-keto 
esters (amides) is presented due to reactivity o f the iodomethyl group. The zinc-mediated 
chain extension-iodomethylation reaction derived from chain extension methylation 








Scheme 18. Zinc-mediated Chain Extension-iodomethylation Reaction
21
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Synthesis of a-Iodomethyl y-Keto Esters
The chain extension-iodomethylation reaction was first conducted on P-keto esters. 
Three representative P-keto esters (methyl pivaloylacetate, benzyl acetoacetate, and t- 
butyl acetoacetate) were chosen as substrates for the chain extension-iodomethylation 
reaction. Based upon previous optimization o f the conditions for the chain extension 
methylation reaction investigated by Hilgenkamp, the iodomethylation reaction was 
performed on the substrates using a similar procedure.10 Exposing P-keto esters to five 
equivalents o f carbenoid derived from the reaction system, followed by addition o f 
catalytic trimethylsilylchloride (0.2 equivalents) and excess iodine, provided the desired 
a-iodomethyl y-keto esters in satisfactory yields after purification by column 
chromatography. The results showed that the efficiency o f chain extension- 
iodomethylation is not hindered by the presence o f a bulky or aromatic group on the ester 
oxygen, which is consistent with the results found in the chain extension methylation 
reaction.
Table 2. Preparation of a-Iodomethyl y-Keto Esters
Entry R R ’ Product(Yield)
1 f-Butyl c h 3 82(58%)
2 c h 3 f-Butyl 83(62%)
3 c h 3 CH2Ph 84 (60%)
From a !H NMR investigation o f the crude reaction mixtures, five compounds were
22
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observed in the reaction o f methyl pivaloylacetate. Those compounds were identified as 
the targeted a-iodomethyl y-keto ester 82, (3-iodomethyl y-keto ester 85, a-iodo y-keto 
ester 86, a-methyl y-keto ester 87 and simple chain-extended product y-keto ester 88. The 
small amount o f compound 86 was believed to result from
85 8 6
87 88
Figure 2. Products in the Crude Mixture o f Iodomethylation Reaction on Methyl
Pivaloylacetate
the chain extended y-keto ester by treatment with iodine prior to quench with saturated 
ammonium chloride solution. This result was probably due to the inefficiency o f the 
chain extension methylation reaction. An easy way to enhance the methylation was to 
increase the reaction time after addition o f TMSC1 to the reaction mixture from 30 min to 
60 min. The compounds 86 and 88 were not observed in the ’ H NMR spectrum of the 
crude mixture after this change was made. The a-methyl y-keto ester 87 could be 
eliminated from the reaction mixture by increasing the equivalents o f iodine from 2.0 to
23
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5.0 and extending the iodonation time to 10 min after the appearance o f a constant purple 
color o f reaction mixture.
The most interesting byproduct, observed in preparation o f the a-iodomethyl y-keto 
ester o f methyl pivaloylacetate, was the P-iodomethyl y-keto ester 85. The compound was 
hard to separate from the a-iodomethyl y-keto ester 82 by column chromatography. When 
comparing NMR spectra o f compounds 82 and 85, a minor difference was the chemical 
shift o f the methine proton adjacent to the iodomethyl group. The proton o f 82 was 
shifted slightly upfield, while the methine proton in 85 was slightly downfield due to its 
location nearer to the ketone carbonyl group. A proposed mechanism to explain the 
appearance o f compound 85 in the chain extension-iodomethylation reaction is illustrated 
in Scheme 19.
An assumption is made that the starting P-keto ester has not completely finished 
undergoing the chain extension reaction before addition of TMS chloride to the reaction 
mixture. This means it is possible for remaining P-keto ester enolate to react with TMSC1, 
which leads to the formation o f TMS enol ether 6. This intermediate could be converted 
to the constitutional isomer 7 because o f the migrating ability o f silicon.3 After reacting 
with the zinc carbenoid, the TMS-protected cyclopropyl alcohol intermediate 8 could be 
presented in the reaction mixture. This hypothesis is similar to Saigo’s chain extension 
method described in chapter I (Scheme 2). Fragmentation o f intermediate 8 provides a 
chain extended zinc species 90. Reaction o f 90 with TMS chloride and excess carbenoid 
would provide the homoenolate 92, which could be converted to P-iodomethyl y-keto 
ester 93 by introduction of iodine to the reaction.
24
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Scheme 19. Proposed Mechanism of Formation o f (3-Iodomethyl y-Keto Esters 93
In order to test this hypothesis, the chain extension time o f the reaction was 
increased from 10 min to 30 min. This modification was used to allow all o f the starting 
compound P-keto ester to be consumed completely before addition of trimethylsilyl 
chloride to the reaction. Use o f thin layer chromatography (TLC) technique can 
effectively monitor the degree o f starting material consumption in the reaction. It was 
observed from the *H NMR spectrum of the crude reaction mixture that the amount of 
byproduct P-iodomethyl y-keto ester dramatically decreased, which supported this 
proposed mechanism. However, no further evidence confirms the existence o f the 
intermediates in this type o f iodomethylation reaction.
25
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Synthesis of a-Iodomethyl y-Keto Amides
Based on the successful formation of a-iodomethyl y-keto esters, the zinc-mediated 
chain extension iodomethylation was studied with P-keto amides as the starting materials. 
Considering the inefficiency o f the chain extension methylation for secondary P-keto 
amides,83 tertiary P-keto amides were viewed as more suitable starting materials for this 
study. The selected P-keto amides were not commercially available, so they were 
prepared by the reaction of diketene with various amines (Scheme 20).34
NaHC03
Scheme 20. The Reaction o f Diketene with Different P-Keto Amides
The first P-keto amide utilized in the iodomethylation reaction was N,N- 
diisopropyl-3-oxo-butyramide 94, which was derived from jV,jV-diisopropylamine. 
Surprisingly, no desired product a-iodomethyl y-keto amide 96 was observed in the crude 
reaction mixture when it was subjected to the iodomethylation conditions. Only a-iodo y- 
keto amide 97 and the chain extended product 98 were observed (Scheme 21).
26
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Scheme 21. The Iodomethylation Reaction with N, A-Diisopropyl-3-oxo-Butyr amide 94
Attempts were made to produce the iodomethylation product o f the P-keto amide, 
including a modification in the amount o f catalytic trimethylsilylchloride (TMSC1) from 
0.2 equivalents to 1.0 equivalents, as well as lengthening the reaction time for 
methylation from 45 min to 90 min. 'H-NMR spectra of the crude reaction mixture 
showed the major product was still the a-iodo y-keto amide 97. The desired a-iodomethyl 
chain-extended product was not formed. As discussed before, the role o f the 
trimethylsilylchloride in the tandem chain extension methylation reaction is believed to 
promote fragmentation o f the dimeric species 23 and generate an activated nucleophile. 
Another more powerful electrophlic TMS-source TMSOTf was used to promote the 
formation o f a-methyl y-keto amide. This effort resulted in slightly higher yield o f the a- 
iodo compound 97, yet no iodomethylated material was obtained.
In addition to TV, A-diisopropyl-3-oxo-butyramide 94, the iodomethylation reaction 
was performed with another P-keto amide substrate, l-(l,3-dioxobutyl) pyrrolidine 95, 
derived from pyrrolidine. The desired compound a-iodomethyl y-keto amide 99 was
27
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
observed in the crude mixture, but the a-iodo y-keto amide 100 was still present in the 
reaction mixture. The target compound 99 derived from pyrrolidine P-keto amide 95 was 
isolated by column chromatography in only 12% yield (Scheme 22). Although similar 
modifications applied to the reaction o f the diisopropylamide substrate were also carried 
out with 95, no improvement in yield was achieved.
O O 
95







Scheme 22. The Iodomethylation Reaction with l-(l,3-Dioxobutyl) pyrrolidine 95
Based on all o f the information obtained from the experiments, it was concluded 
that the tandem zinc-mediated chain extension-iodomethylation reaction does not work 
efficiently with some P-keto amides; however, this does not mean that all p-keto amides 
would be unreactive, since earlier work by Hilgenkamp demonstrated that some P-keto 
amides, such as an A, A-dimethyl-3-oxobutyramide, can be converted to the desired Di­
methyl y-keto amides using the tandem chain extension-methylation reaction.7 A likely 
explanation for the failure o f A  A-di isopropyl P-keto amide 94 and pyrrolidine P-keto
28
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amide 95 in the iodomethylation reaction is that the methylation reaction is somehow 
hindered by the presence o f bulky amide substituents. The steric hindrance may obstruct 
the ability o f the amide carbonyl to form the TMS enol ether by reaction with TMSC1.
Synthesis of a-Iodomethyl y-Keto Imides
In an effort to broaden the scope of the zinc-mediated chain extension 
iodomethylation reaction, the methodology was applied to a P-keto imide starting 
material, derived from an oxazolidinone precursor. Oxazolidinones derived from chiral 
amino acids are frequently referred to as Evans’ auxiliaries, which have been used widely
i f
for asymmetric synthesis. The utility o f chiral oxazolidinone P-keto imides in the zinc- 
mediated chain extension-aldol reactions has been investigated by Lai and Lin.36 
Incorporation of the chiral oxazolidinone onto an amino acid-derived starting material 
has proven to be effective for formation o f the chiral P-keto imide used for 
diastereoselective chain extension-aldol reactions. We felt the chiral auxiliary would be 
attractive for the control o f stereochemistry at the a-carbon of iodomethylation products.
Before introducing the chiral auxiliary P-keto imide to this study, an achiral 
oxazolidinone P-keto imide was exposed to the chain extension iodomethylation reaction 
conditions. The P-keto imide 101 can be generated in a yield o f 36% through reaction 
between diketene and oxazolidinone in the presence of strong base n-butyl lithium. The 
iodomethylated compound 102 was isolated by column chromatography in 31% yield 
(Scheme 23).
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102 (31%)
Scheme 23. Preparation of an Oxazolidinone (3-Keto Imide 101 and Its Iodomethylated
Product 102
Previous studies reported by Lin36b showed that one predominant cyclopropanol 
derivative was separated from the crude mixture when the chain extension-aldol reaction 
was performed on a peptide-derived P-keto imide. A similar phenomenon occurred in the 
chain extension-iodomethylation o f the oxazolidinone P-keto imide. The interpretation 
was that the imide functional group enhanced the formation o f a TMS-enol ether 
intermediate 104 due to its ability to react with the TMS group, which was available in 
the reaction system, while the imide carbonyls chelated with zinc (II) in the chain 
extension-aldol reaction. The proposed mechanism involves spontaneous alkylation of 
the TMS-enol ether 104 with the excess carbenoid.
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Scheme 24. Proposed Mechanism for Cyclopropanation
If the cyclopropyl alcohol was formed via this mechanism, the cyclopropyl alcohol 
could be easily formed when performing the methylation reaction. The existence o f TMS 
chloride might promote formation of the TMS enol ether intermediate, which could attack 
the zinc carbenoid to generate the cyclopropyl alcohol derivative through an 
intramolecular cyclization process. Experimental data (Scheme 25) showed that the ratio 
o f methylated product 108 to cyclopropanol 107 decreased significantly with the 
increasing amount o f catalytic TMS chloride equivalents. This indicated that TMS 
chloride played an important role in promoting the formation of the byproduct 
cyclopropyl alcohol. Furthermore, evidence also depicted that longer reaction time for the 
methylation helped to generate the cyclopropyl side product. Limiting the amount of
31
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TMS chloride and limiting the reaction time would be necessary to maximize the yield o f 
the desired iodomethylated compound and reduce cyclopropanol formation.
J T\ I b)TMSCl(AorB)
0°C, 30 min






B= 0.4 equiv 0.7 (22%)
Scheme 25. Chain Extension Methylation on an Oxazolidinone (3-Keto Imide 101
Control of stereochemistry at the a-carbon site is both essential and a challenge in 
the preparation o f ketomethylene isosteres. In order to achieve stereo-controlled a- 
substitution, an approach which utilized a chiral P-keto imide was undertaken. Reduction 
of the amino acid L-phenylalanine 109 with borane dimethylsulfide followed by 
sequential reactions with triphosgene and diketene, provided the chiral P-keto imide 112. 
The chiral P-keto imide was exposed to the same conditions as used in the 
iodomethylation reaction of compound 101. The synthetic route to a chiral a-iodomethyl 
y-keto imide is illustrated on Scheme 26.
From integration o f the *H NMR spectrum of the crude reaction mixture, it was 
found that the ratio o f diastereoisomers o f a-iodomethyl y-keto imide 113 was over 5 to 1, 
indicating that the chiral auxiliary o f the P-keto imide controls the stereochemistry at the 
a-position in the chain extension iodomethylation reaction. However, the yield of 
compound 113 was only 26%.
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Scheme 26. Synthesis of a-Iodomethyl y-Keto Imide 113 through Chain Extension
Iodomethylation Reaction
As anticipated before, due to the similarity with the achiral P-keto imide, a 
considerable amount o f cyclopropyl alcohol 114 was also isolated by column
chromatography from the reaction mixture in a yield of 28%. The diastereoisomeric
cyclopropanols were produced in a ratio (dr) o f over 19:1. In agreement with the previous 
result that the TMSC1 promotes the formation o f cyclopropyl alcohol, the yield of 
isolated compound 114 was increased to 41% when the amount o f TMSC1 was increased 
from 0.2 equivalents to 1.0 equivalents. Another modification to increase the yield of 
cyclopropyl alcohol 114 was to lengthen the reaction time of the methylation prior to the 
addition o f iodine to the reaction mixture. The data showed that the yield o f compound 
114 increased when the methylation time was changed from 1 hr to 2 hr. In the meantime
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the amount of iodomethylated compound 113 decreased to a similar degree.
Table 3. Yields o f Compound 113 and 114
Entry Compound 113 Compound 114
TMSC1 = 0.2 equiv
Methylation: 1 hr 26% 28%
Methylation: 2 hr 23% 35%
TMSC1 -  1.0 equiv Methylation: 1 hr 20% 41%
It is unclear what factors effectively control the stereoselectivity o f the cyclopropyl 
alcohol formation. In another words, it is unclear which diastereomer converts faster to 
the cyclopropanol. When treating the compound 96 with diethylzinc for a couple o f hours, 
no cyclopropyl alcohol 114 was observed in the reaction mixture.
One predominant isomer o f the cyclopropanol 114 was obtained using the chiral 0- 
keto imide as the starting material. Since the cyclopropyl alcohol is a solid, it will be 
possible to identify the relative configurations o f the product by X-ray crystallographic 
analysis. Efforts to grow an X-ray quality crystal are underway. Fragmentation o f the 
cyclopropane ring in 114 might provides access to a chiral homoenolate, which would be 
o f great interest on organic synthesis. Interest in the cyclopropyl alcohol may also be 
found in its use as a sp -hybridized transition state mimic for peptide hydrolysis.
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Incorporation of Side Chain on a-Carbon Site of an a-Iodomethyl y-Keto Ester 
1) Palladium-catalyzed Cross-coupling Reaction
As described above, efficient formation o f peptide isosteres requires that 
appropriate functional groups be installed as side chains. Preferably, these side chains 
will have identical functionality and stereochemical orientation with those found in the 
natural amino acids system. The successful preparation o f a-iodomethylated y-keto esters 
provided an iodomethyl group at the a-carbon site. This iodomethyl substituent was 
proposed to be useful for the a-side chain mimics due to the high reactivity o f iodide. A 
strategy in which transmetallation-coupling reaction would be utilized to attach a variety 
o f carbon skeletons to the a-iodomethyl group was proposed.
A transmetallation-coupling reaction, also called cross-coupling, involves the reaction 
between an organometallic reagent R-M with an organic compound R ’-X, where X is a 
leaving group activated by a transition metal like palladium or nickel.37
R-M + R ’-X PdorN l»  R-R’
Scheme 27. Metal-catalyzed Cross-coupling Reaction
Due to the central importance o f coupling reactions in the formation o f new carbon- 
carbon bonds in organic synthesis, cross-coupling reactions have been investigated 
intensively over the last thirty years.38 Many transition metals are capable o f promoting 
and catalyzing this type o f reaction, including palladium, copper, nickel and iron. 
Palladium has proved to be the most broadly employed and powerful catalyst for
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facilitating carbon-carbon bond formation through a variety o f cross-coupling reactions. ’ 
40 Palladium-catalyzed cross-coupling reactions would be expected to facilitate the goal 
o f incorporating a-side chains that mimic those found in nature. Generally, iodides and 
bromides have been used as the organic acceptors (carbon electrophile) in Pd-catalyzed 
cross coupling reactions. A variety o f metals, including tin, zinc, aluminum, boron or 
silicon, can be employed as the organometallic donors in this type o f reaction. To 
investigate the Pd-catalyzed cross-coupling reaction on the iodomethylated y-keto 
product 82, a Negishi coupling reaction41 was utilized to this study. The palladium 
complex tris (dibenzyllideneacetone)dipalladium was selected as the catalyst in 
collaboration with the tri-(o-tolyl)phosphine ligand. Zinc metal also was introduced to 
make the organozinc compound from the iodomethylated material 82. Since aryl iodides 
are generally more reactive than bromides or chlorides with the zero valent palladium
'y
complex, different sp -hybridized iodides were employed in this study. The Pd-catalyzed 
Negishi cross-coupling reaction is considered to proceed via a catalytic cycle, as 
summarized in Scheme 28.
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Scheme 28. Proposed Mechanism of Pd-catalyzed Negishi Coupling Reaction
The procedure was carried out by exposing the a-iodomethyl y-keto ester 82 to the 
mixture o f zinc dust (1.4 equiv.) and a small amount o f iodine in DMF at 0 °C for 30 min 
under a nitrogen atmosphere to produce a solution o f an intermediate organozinc reagent. 
The iodobenzene derivative (1.2 equiv.), tris (dibenzyllideneacetone)dipalladium(O) (0.05 
equiv.), and tri-(o-tolyl)phosphine (0.2 equiv.) were added to the reaction mixture. The 
reaction mixture was heated to 60 °C and stirred for 5 h with the cross-coupling reaction 
taking place through the action of the palladium catalyst.42 In order to investigate the 
generality o f the cross-coupling reaction with the chain extended system, different sp2- 
hybridized iodides were used in the cross-coupling reaction. Some o f these compounds 
were selected since they possess similar functional groups to those found in the skeleton 
o f peptide inhibitors, such as Ruprintrivir,43 and natural amino acids, like L-leucine.
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DMF, 60°C, 5 h
115 R = H: 30%
116 R = Cl: 25%
Scheme 29. Preparation o f a-Alkylated y-Keto Ester via Pd-catalyzed Negishi Coupling
Reaction
The first effort to form an a-alkylated y-keto ester through a Pd-catalyzed Negishi- 
coupling reaction utilized a-iodomethyl y-keto ester 82 and iodobenzene (Scheme 29). 
The desired a-alkylated compound was separated successfully from the crude mixture 
after column chromatography. Compound 115 can be used to mimic the side chain o f the 
amino acid phenylalanine. Compared with the organic synthesis procedure reported by 
Jackson et al42, in which a similar procedure was used (Scheme 30) to produce a coupling 
product from 35% to 39% yield, the 30% yield for the formation o f the a-alkylated y-keto 
ester 115 is not unexpected.
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Scheme 30. Synthesis o f AL(fer/-Butoxycarbonyl)-P-[4-(methoxycarbonyl)benyl]alanine
Methyl Ester
Another aromatic iodide derivative, l-chloro-4-iodobenzene was also employed in 
this type o f cross-coupling reaction with the same a-iodomethyl y-keto ester 82. Pure a- 
alkylated y-keto ester 116 was obtained in a 25% yield.
Since the organozinc intermediate, which would be used in the following cross­
coupling reaction, was generated in the methylation process without addition o f iodine, in 
order to simplify the steps o f these reactions, an one-step of chain extension methylation- 
Pd-catalyzed cross-coupling reaction was attempted. Toluene was used as a solvent in the 
chain extension methylation reaction instead of dichloromethane. The cross-coupling 
reaction was preformed between the unisolated organozinc intermediate and iodobenzene 
under similar conditions. No desired a-alkylated compound 115 was obtained by column 
chromatography. The major product was a-methylated y-keto ester 36. It indicated the 
cross-coupling does not take place under this one-step procedure (Scheme 31).
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Scheme 31. Attempted One-step Pd-catalyzed Cross-coupling Reaction
The a-alkylated y-keto ester that was incorporated with iodophenol, which could 
mimic the side group of the amino acid tyrosine, was expected to be generated through 
the Pd-catalyzed cross-coupling reaction. Because the acidic proton on iodophenol would 
quench the zinc intermediate generated in-situ by zinc insertion o f a-iodomethyl y-keto 
ester 82, protection o f the OH group was required. t-Butyldimethylsilyl chloride was used 





Scheme 32. Protection o f Iodophenol with TBDMSC1 and Acetic Anhydride
The effort to produce compound 119 (Scheme 33) in the cross-coupling reaction 
was failed. No targeted compound was observed in the crude reaction mixture or after
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column separation. When compound 82 was only treated with zinc dust and a small 
amount o f iodine, the a-methyl y-keto ester 87 was generated from the aqueous quench o f 
the organozinc intermediate. This study indicated that the zinc insertion process was 
successful in the first step o f the reaction. Some modifications were attempted in the 
cross-coupling reaction, including increasing the reaction time from 5 h to 24 h, and 
using an acetyl protecting group (with better electron withdrawing capability) instead of 
the TBDMS group. No evidence for the formation o f the target compound in the reaction 
mixture was found. The oxygen donates electron density to the aromatic ring, which may 
play a role in hindering palladium insertion into the iodophenol, thus resulting in the 
failure o f new carbon-carbon bond formation.
.OPG
■OPG
PG = TBDMS 119 or Acetyl 12082
Scheme 33. Attempted Preparation o f a-Alkylated y-Keto Ester with Protected 
Iodophenol via Pd-catalyzed Cross-coupling Reaction
In addition to the study of the a-iodomethylated y-keto ester 82, the Pd-catalyzed 
cross-coupling reaction between a-iodomethyl y-keto imide 1 0 2  and iodobenzene was 
also studied. The same procedure was followed as described above (Scheme 34). The 
desired coupled compound 1 2 1  was successfully isolated from the crude reaction mixture 
in a yield o f 23%.
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102
Pd2dba3, P(0-Tol)3  
DMF, 60°C, 5 h 121
Scheme 34. Preparation o f a-Alkylated y-Keto Imide 119 via Pd-catalyzed Negishi
Coupling Reaction
In order to expand the scope of the cross-coupling reaction as applied to the a- 
iodomethylated y-keto ester system, another substrate, 2-bromopropene, was utilized. The 
reaction with a-iodomethyl y-keto ester 82 followed a similar procedure as described for 
the aryl iodides. Since 2-bromopropene has a low boiling point (42-47 °C), careful 
control o f reaction conditions was required. The desired a-alkylated y-keto ester 122 was 
successfully obtained in a 25% yield. Because the compound 122 incorporated a new 
carbon-carbon double bond in its molecular structure, it was possible to further 
manipulate the a-substituent. Treatment of 122 with hydrogen in the presence o f 
palladium on carbon provided compound 123, which was easily isolated by column 
chromatography using a pipette. Compound 123 contains a side chain that effectively 
mimics the side chain o f the amino acid leucine. All o f the information gained from these 
methodological studies suggests that the zinc-mediated chain extension-iodomethylation 
product provides an opportunity to incorporate a substituent at the a-carbon site o f the 
extended chain, thereby facilitating the regio-controlled a-substitution for the efficient 
mimicry o f peptide systems.
4 2
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DMF, 40 °C, overnight 
82 122 (25%)
123 (59%)
Scheme 35. Preparation o f the Compound 122 and 123
2) Attempted Synthesis of a Ketomethylene Isostere
Based upon the successful results from the study on the chain extension 
iodomethylation methodology and in order to demonstrate the utility o f the tandem chain 
extension-iodomethylation chemistry, the preparation o f ketomethylene isostere 124, 
which is a key component o f peptide inhibitor Ruprintrivir 125, was proposed. The 
proposed synthetic approach is illustrated in Scheme 36.
c h3





Figure 3. The Ketomethylene Isostere 124 and Ruprintrivir 125
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L-Valine was selected as starting material for the synthesis o f target 124. Since 
tandem chain extension-iodomethylation reactions are sensitive to the presence of a 
proton source, which would quench the enolate and/or homoenolate prior to the 
introduction of iodine, appropriate protection o f the amino acid is required. Previous 
studies on the protection of amino acids were carried out by Tryder45 and Lin.36b A variety 
o f protecting groups used for amino acids have been shown to be tolerated in the chain 
extension reaction; therefore, an effective two-step protection sequence was developed. 
The first step involved protection with a /?ara-methoxybenzyl group (Pmb) through 
treatment o f L-valine with />anisaldehyde, followed by reduction using sodium 
borohydride. The Pmb-protected amino acid 126 was produced in a good yield. However, 
the nucleophilic nitrogen atom was assumed to be incorporatible with the electrophilic 
carbenoid used in the chain extension reaction, so further protection on the amino group 
was needed. The carbobenzyloxy (Cbz) group is a very common protecting group for 
amino acids in peptide synthesis, and was believed to be suitable for protecting the amine 
group to its electron withdrawing character. Incorporation o f the Cbz group onto the 
Pmb-protected amino acid 126 proceeds in an aqueous sodium hydroxide solution, which 
is used to scavenge the HC1 generated from the reaction of Cbz chloride and amine. The 
TV-protected amino acid 127 was obtained in a good yield.
4 4







































Scheme 36. Attempted Synthetic Approach to a Ketomethylene Isostere 124
In this synthetic route to target compound 124, the key step was to prepare the 
desired chiral P-keto imide 129 that could be used as a substrate in the zinc-mediated 
chain extension-iodomethylation and Pd-catalyzed cross-coupling reaction. The 
generation o f the P-keto imide from amino acid was performed through a modified 
Claisen condensation using a method developed by Lin (Scheme 38). Activation o f the 
protected-valine through treatment with carbonyl diimidazole at room temperature in
45
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THF formed acyl imidazole 132. Then the acyl imidazole solution was transferred to 
another solution, in which the iV-acetylated oxazolidinone 128 had been deprotonated by 
lithium diisopropylamide (LDA) to form an enolate intermediate. The chiral P-keto imide 




Scheme 37. Preparation o f Compound 128 from D-phenylalanine
Self-condensation o f compound 128 during treatment with LDA occurs under these 
reaction conditions, so slow addition o f compound 128 to the LDA solution was crucial 
to achieve efficient formation of 129. On the other hand, the acidic character o f 129 
presents ability to quench the enolate intermediate. The imidazole byproduct 133, 
generated from the activation of the acid, can also act as a proton source to consume the 
enolate during the reaction process, so in order to maximize the yield of chiral P-keto 
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Scheme 38. Synthesis of Chiral P-Keto Imide 129 through a Modified Claisen
Condensation Reaction
The zinc-mediated chain extension-iodomethylation reaction was conducted on the 
chiral P-keto imide 129 to generate the corresponding a-iodomethyl y-keto imide 130 in a 
yield o f 46% under the same conditions as used with previous P-keto imides. The *H 
NMR spectrum of the purified compound 130 was difficult to interpret, due to the
1 -j
coexistence o f rotamers and diastereomers. The C NMR spectrum revealed an upfield 
peak (chemical shift 8  4.7), which corresponded to a carbon attached to an iodine atom. 
This peak was characteristic in all o f the a-iodomethylated y-keto compounds prepared in 
this study. Evidence from the MS spectrum (ESI) also strongly supported the conclusion 
that 130 was indeed obtained through the iodomethylation reaction, in which the value of 
the largest peak (m/z 749) was consistent with the molecular weight (726) o f 130 plus a 
sodium ion (23). The ratio o f diastereoiosomers and absolute configuration o f the a- 
carbon is still unknown. Further study on the stereo-controlled iodomethylation is
4 7
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required.
Unfortunately no cross-coupling product 131 was generated when compound 130 
was reacted with l-fluoro-4-iodobenzene. The complicated structure o f compound 130
ester 82 was used in a cross-coupling reaction with l-fluoro-4-iodobenzene (Scheme 39). 
No coupling product 135 was observed in this reaction, although the side products a- 
hydroxymethyl y-keto ester 136 and tri-(o-tolyl)phosphine oxide 137 were shown to be 
present in the reaction mixture by NMR and MS spectroscopy. These results suggest that
l-fluoro-4-iodobenzene does not participate in this cross-coupling reaction; however 
further investigation o f this question needs to be carried out in the future.
Scheme 39. Attempted Synthesis of a- Alkylated y-Keto Ester 135 with l-Fluoro-4- 
Iodobenzene and Side Products 136 and 137
might be a factor in inhibiting the coupling reaction. Therefore the a-iodomethyl y-keto
F
82
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3) Other Applications
As described earlier in chapter II, the anticipated high reactivity o f the iodide 
formed in the product o f zinc-mediated chain extension-iodomethylation reaction could 
be used to attach different groups to the a-position, thereby mimicking the side chain o f 
natural amino acids such as cysteine and glutamic acid.
A previous attempt to make a ketomethylene peptide mimic with cysteine-like side 
chain was made by Emerald Wilson in the Zercher research group .46 The data showed the 
a-iodomethyl y-keto ester 82 did not react with thiourea to make an isothiuronium salt 
138, which presumably could have been converted to a cysteine derivative 139. The 
methylated material 87 was identified by 'H  NMR as well as other byproducts (Scheme
Alternative nucleophilic sulfur reagents were investigated for the preparation o f the 
compound 139 in the present study, including sodium sulfide and sodium hydrogen
40).
87
Scheme 40. Attempted Formation o f Isothiumium Salt 138
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sulfide. The literature reports that several pathways have been used for the preparation of 
thiols from iodides.47 Since sulfur-containing compounds are easily oxidized and thiols 
are excellent nucleophiles, excess amounts o f Na2S or NaSH (10 equiv.) were employed 
in these thiolation reactions to avoid the formation of thioether 140 and dimeric species 
141. Unfortunately, the major compound identified by *H NMR and MS (ESI) analyses 
was the thioether 140 rather than the desired compound 139. The isolated yield o f 140 
was about 28-30%. The minor dimeric form o f compound 141 was isolated from the 
crude mixture, which was readily converted to 139. The limited solubility o f the sodium 
salts slowed its participation as a nucleophile, while the thiolate intermediate was nicely 
soluble; therefore formation of 140 was difficult to avoid. Modifications, including an 
attempt to increase the solubility o f Na2S by using more solvent (DMF) or by using a 




Scheme 41. Formation o f Thioether 140 and Dimeric Species 141 o f Compound 139
Due to the unsatisfactory result described above, an alternative approach to the 
incorporation o f a sulfur on the side chain was attempted. Treatment o f iodide 82 with
A O
potassium thioacetate provided the acetyl-protected thiol 142. Conversion o f the
50
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protected sulfur compound 142 to the target compound 139 was attempted through 
removal o f the acetyl group using sodium methoxide in a methanol solution (Scheme 42). 
Surprisingly, no desired compound 139 was observed in the crude mixture. The presence 
o f compounds 140 and 141 were identified by mass spectrum. Moreover, compound 139 
was not observed from mass spectral data o f the crude reaction mixture during the 
reaction period. Although the acetyl group was never successfully removed in this study, 
its removal is well precedented.48c This strategy o f iodide displacement with a sulfur 







Scheme 42. Attempted Formation o f Compound 139 Using Protected Sulfur Compound
142
The product o f the tandem zinc-mediated chain extension-iodomethylation reaction 
could also be used to install a carboxylate functionality on the a-carbon site o f the 
extended chain through nucleophilic alkylation. An initial study on this application was 
conducted through the use of dimethyl malonate. The dimethyl malonate was treated with 
a strong base and reacted with the a-iodomethyl y-keto ester 82 to generate a-alkylated 
compound 143, which could be converted to compound 144 by further decarboxylation 
(Scheme 43).49 The decarboxylated product would mimic the side group o f glutamic acid.
51
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The compound 141 was successfully obtained using this strategy; however, the 
coexistence o f three methyl ester groups in the same molecule provides a challenge for 
the subsequent ester cleavage and decarboxylation. The use o f an alternative malonate 
reagent with easily removable ester groups, such as benzyl t-butyl malonate, would be 









Scheme 43. Nucleophilic Alkylation on Compound 82
In summary, the products formed in the tandem chain extension iodomethylation 
reaction could be utilized in subsequent chemistry, which provides a facile means to form 
side chains suitable for peptide isosteric replacements.
52
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CHAPTER III
CONCLUSION
A new efficient methodology for the preparation of a-substituted y-keto esters, 
amides and amino acid-derived imides has been developed. A tandem zinc-mediated 
chain extension-iodomethylation reaction, which is derived from the zinc-mediated chain 
extension methylation reaction, has been successfully applied to a variety o f P-keto esters, 
amides and imides. This one-pot approach containing three distinct steps facilitates the 
efficient preparation o f ketomethylene isosteres, which are proven inhibitors for various 
enzymatic systems. The yields for the formation of a-iodomethyl y-keto esters were 
higher than for the formation of a-iodomethyl y-keto amides. p-Keto amides with bulky 
groups on the amide bond did not react efficiently under the zinc-mediated chain 
extension-iodomethylation reaction conditions.
Evidence showed that exposure of a chiral P-keto imide to the chain 
extension-iodomethylation reaction conditions provides an a-iodomethyl y-keto product 
with high diastereoselectivity (de>80%). Furthermore, one predominant isomer o f a 
cyclopropane product was obtained from the chiral P-keto imide. When an increase in the 
amount of catalytic TMSC1 was used, an improved yield o f the cyclopropanol was 
realized. The absolute configuration o f the a-position o f the cyclopropanol isomer has not 
been assigned. These data indicate that a chiral P-keto imide promotes the 
stereocontrolled incorporation o f substituents at the a-position of the extended chain.
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It is believed that the mechanism of the zinc-mediated chain extension 
-iodomethylation reaction involves a donor-acceptor cyclopropane intermediate, which 
fragments to provide a zinc enolate intermediate. Exposure o f the zinc enolate to TMS-C1 
promotes the formation o f a reactive TMS enol ether, which reacts with another 
equivalent o f the zinc carbenoid to generate a zinc homoenolate. This zinc homoenolate 
can be utilized in further tandem reaction processes to generate products which possess 
an appropriately positioned a-side chain for the effective mimicry o f peptide bonds. 
Different substrates were successfully incorporated to generate a-sustituted y-keto esters 
and imides in modest yields.
In one application of the homoenolate-derived product, a palladium-catalyzed 
cross-coupling reaction was used to derivitize the a-iodomethylated product. The 
cross-coupling reaction facilitated the incorporation of a a-substitution suitable for 
peptide isosteres; however, some aromatic halides, including iodophenol and 1 -fluoro- 
4-iodobenzene, did not react with the a-iodomethylated product in this palladium- 
catalyzed cross-coupling reaction.
The a-iodomethylated products were utilized as substrates in other applications, 
such as thiolation and nucleophilic alkylations, to attach different alkyl groups at the 
a-position.
54




Unless otherwise noted, all reactions were run in oven-dried glassware and stirred 
with teflon-coated magnetic stir-bars. The term concentrated under reduced pressure 
refers to the use o f a rotary-evaporator or vacuum pump.
a) Solvents
Methylene chloride (CH2CI2), tetrahydrofuran (THF), diethyl ether (Et2 0 ), 
AUV-dimethylformamide (DMF) and methanol were dried by passing the solvent through 
a column o f alumius or molecular sieves using an Inovative Technology Inc. solvent 
delivery system. Ethyl acetate (EtOAc) and hexanes used for chromatography were 
purchased from Pharmco and distilled prior to use.
b) Reagents
Unless otherwise noted, all reagents were purchased from commercial suppliers and 
used without further purification. Diethylzinc was purchased both as a solution (1.0 M in 
hexane) and neat. Methylene iodide (CH2 I2) was purchased from Lancaster Chemical. 
Non-oxidized copper wire was added as a stabilizer. Iodine was sublimed prior to use.
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Trimethylsilylchloride (TMS-C1) was distillated from calcium hydride under a nitrogen 
environment and stored over 4 A sieves.
Tris(dibenzyllideneacetone)dipalladium(0) and tri-(o-tolyl)phosphine were 
purchased from Aldrich Chemical Co. and used without further purification. Palladium 
10% on carbon was purchased from Aldrich Chemical Co. and used without purification.
c) Chromatography
Column chromatography was performed with Sorbent Technologies flash silica gel 
(32-63 pm). The mobile phase was prepared as noted in the individual experimental 
section. Thin Layer Chromatography (TLC) was carried out on EM Science F254 glass 
plates and visualized by UV and anisaldehyde or KMnC>4 stains.
d) Spectroscopy
Nuclear Magnetic Resonance (NMR) spectroscopy was performed on Varian 
Mercury operating at 399.768 MHz for 'H nuclei and 100.522 MHz for 13C nuclei, and 
Varian Inova operating at 499.766 MHz for ]H nuclei and 125.679 MHz for I3C nuclei.
1 o  1
All C are H-decoupled. Unless otherwise noted, all NMR experiments were carried out 
in deuterochloroform (CDCI3) solvent purchased from Cambridge Isotope Laboratory 
and stored over 4 A sieves. All chemical shifts are reported in parts per million (ppm) 
downfield of tetramethylsilane (TMS) internal standard.
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Mass Spectrometry (Electronic Scanning Ionization) was performed on a Thermo 
Finnigan LCD instrument. Mass Spectrometry (Matrix Assisted Laser Desorption 
Ionization) was performed on an Axima instrument. Infrared spectroscopy was performed 
on a Nicolet 205 Fourier Transform spectrometer.
e) Experimentation
Melting points were determined using an Electrothermal 9100 digital melting point 
apparatus and are uncorrected. Optical rotations were conducted using a Rudolph 
Research AUTOPOL III automatic polarimeter in specified solution and concentrations 
are given in g/mL.
2. Preparation of a-Iodomethyl y-Keto Esters 
2-Iodomethyl-5, 5-dimethyl-4-oxo-hexanoic acid methyl ester 82
An oven-dried, one-necked, 50-mL round-bottomed flask equipped with a rubber
septum and magnetic stir-bar was cooled to room temperature under a nitrogen 
atmosphere, and charged with 15 mL of methylene chloride. The solvent was cooled to 
0 °C in an ice bath and methylene iodide (0.32 mL, 4.0 mmol) was added dropwise into 
the flask. Diethyl zinc (4.0 mL, 1.0 M in hexane, 4.0 mmol) was added slowly to the 
reaction mixture at 0 °C over two min. The resulting white suspension was stirred for 10 
min, and then methyl pivaloylacetate (0.16 mL, 1.0 mmol) was added rapidly. After the
57
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solution was stirred for 30 min, trimethylsilylchloride (25 |iL, 0.2 mmol) was added in 
one portion by micro-syringe. The mixture was allowed to stir for 45 min at room 
temperature followed by the addition o f iodine (1.269 g, 5.0 mmol) to the reaction 
mixture. The reaction mixture quickly became a pink suspension and was stirred for 10 
min, quenched with 10 mL of saturated aqueous ammonium chloride, and extracted with 
diethyl ether (3x10 mL). The combined organic layers were washed with saturated 
sodium thiosulfate solution (2x15 mL), and brine (3x20 mL), dried over anhydrous 
sodium sulfate, fdtered, and concentrated under reduced pressure (25 °C, 30 torr). The 
residue was purified by column chromatography on silica (30:1, hexane: ethyl acetate, R/ 
= 0.16) to yield 0.128 g (41%) o f 2-iodomethyl-5,5-dimethyl-4-oxo-hexanoic acid methyl 
ester 82 as a clear yellow liquid. ]H NMR (400 MHz, CDCI3) 8  3.73 (s, 3 H), 3.45 (dd, 
J =  6.0, 10.0 Hz, 1 H), 3.38 (dd, 7 =  5.4, 10.0 Hz, 1 H), 3.20 (m, 1 H), 3.11 (dd, J =  7.0, 
17.9 Hz, 1 H), 2.80 (dd, J  = 5.4, 18.0 Hz, 1 H), 1.18 (s, 9 H); 13C NMR (100 MHz, 
CDCI3) 5 213.3, 172.5, 52.6, 44.3, 42.0, 39.2, 26.8, 6.3; IR (neat, cm '1): 2967, 1738, 
1705, 1477, 1366, 1232.
2-Iodomethyl-4-oxo-pentanoic acid tert-butyl ester 83
An oven-dried, one-necked, 50-mL round-bottomed flask equipped with a rubber 
septum and magnetic stir-bar was cooled to room temperature under a nitrogen 
atmosphere, and charged with 15 mL of methylene chloride. The solvent was cooled to 
0 °C in an ice bath and methylene iodide (0.32 mL, 4.0 mmol) was added dropwise into
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the flask. Diethyl zinc (4.0 mL, 1.0 M in hexane, 4.0 mmol) was added slowly to the 
reaction mixture at 0 °C over two min. The resulting white suspension was stirred for 20 
min, and then t-butyl acetoacetate (0.17 mL, 1.0 mmol) was added rapidly. After the 
solution was stirred for 30 min, trimethylsilylchloride (25 pL, 0.2 mmol) was added in 
one portion by micro-syringe. The mixture was allowed to stir for 45 min at room 
temperature followed by the addition o f iodine (1.269 g, 5.0 mmol) to the reaction 
mixture. The reaction mixture quickly became a pink suspension and was stirred for 10 
min, quenched with 10 mL of saturated aqueous ammonium chloride, and extracted with 
diethyl ether (3x10 mL). The combined organic layers were washed with saturated 
sodium thiosulfate solution (2x15 mL), and brine (3x20 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure (25 °C, 30 torr). The 
residue was purified by column chromatography on silica (15:1, hexane: ethyl acetate, R/ 
= 0.15) to yield 0.201 g (63%) of 2-iodomethyl-4-oxo-pentanoic acid tert-bu\y\ ester 83 
as a clear yellow liquid. !H NMR (400 MHz, CDC13) 6  3.46 (dd, J =  5.6, 9.9 Hz, 1 H), 
3.35 (dd, J=  4.4, 9.9 Hz, 1 H), 3.07 (m, 1 H), 3.00 (dd, J=  5.5, 17.6 Hz, 1 H), 2.62 (dd, J  
= 5.0, 17.6 Hz, 1 H), 2.20 (s, 3H), 1.46 (s, 9 H); 13C NMR (100 MHz, CDC13) 5 206.0, 
170.8, 82.0, 45.3, 42.5, 30.4, 28.1, 7.3.
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2-Iodomethyl-4-oxo-pentanoic acid benzyl ester 84
An oven-dried, one-necked, 50-mL round-bottomed flask equipped with a rubber 
septum and magnetic stir-bar was cooled to room temperature under a nitrogen 
atmosphere, and charged with 15 mL of methylene chloride. The solvent was cooled to 
0 °C in an ice bath and methylene iodide (0.32 mL, 4.0 mmol) was added dropwise into 
the flask. Diethyl zinc (4.0 mL, 1.0 M in hexane, 4.0 mmol) was added slowly to the 
reaction mixture at 0 °C over two min. The resulting white suspension was stirred for 10 
min, and then benzyl acetoacetate (0.18 mL, 1.0 mmol) was added rapidly. After the 
solution was stirred for 30 min, trimethylsilylchloride (25 pL, 0.2 mmol) was added in 
one portion by micro-syringe. The mixture was allowed to stir for 45 min at room 
temperature followed by the addition o f iodine (1.269 g, 5.0 mmol) to the reaction 
mixture. The reaction mixture quickly became a pink suspension and was stirred for 10 
min, quenched with 10 mL of saturated aqueous ammonium chloride, and extracted with 
diethyl ether (3x10 mL). The combined organic layers were washed with saturated 
sodium thiosulfate solution (2x15 mL), and brine (3x20 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure (25 °C, 30 torr). The 
residue was purified by column chromatography on silica (25:1, hexane: ethyl acetate, R/ 
= 0.21) to yield 0.208 g (58%) of 2-iodomethyl-4-oxo-pentanoic acid benzyl ester 84 as a 
clear yellow liquid. *H NMR (400 MHz, CDCI3) 8 7.36 (s, 5 H), 5.15-5.14 (m, 2 H), 3.48 
(dd, J  = 7.5, 11.4 Hz, 1 H), 3.39 (dd, J =  4.6, 10.1 Hz, 1 H), 3.23 (m, 1 H), 3.06 (dd, 7  =
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CDC13) 5 205.8, 171.7, 135.6, 128.8, 128.7, 67.5, 45.3, 41.9, 30.4, 6.1.
3. Preparation of P-Keto Amides 
N, TV-Diisopropyl-3-oxo-butyramide 94
An one-necked, 50-mL round-bottomed flask equipped with a rubber septum and 
magnetic stir-bar was charged with 15 mL of deionized water. iV,iV-Diisopropylamine 
(2.8 mL, 20 mmol) and diketene (2.3 mL, 30 mmol) were added into the reaction flask. 
The reaction mixture was stirred at room temperature for 4 h, quenched with 10 mL of 
saturated citric acid solution, and extracted with ethyl acetate (3 x2 0  mL). The combined 
organic layers were washed with saturated sodium bicarbonate solution (2x10 mL), and 
brine (3x15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure. The residue was purified by column chromatography on silica (9:1, 
hexane: ethyl acetate, R/ = 0.25) to yield 1.54 g (42%) o f A/,7V-diisopropyl-3-oxo- 
butyramide 94 as a clear orange liquid. The dicarbonyl was in equilibrium with the enol 
form. JH NMR (400 MHz, CDC13) 5 3.49 (s, 2 H), 2.26 (s, 3 H), 1.40 (d, J =  6 . 8  Hz, 6  
H), 1.19 (d, J = 6.7 Hz, 6  H); enol form: 8  5.10 (s, 1 H),. 1.96 (s, 3 H), 1.40 (d, J=  6 . 8  Hz, 
6  H), 1.19 (d, J  = 6.7 Hz, 6  H); 13C NMR (100 MHz, CDC13) 8  203.3, 165.7, 52.6, 50.0, 
46.2,30.2,20.9,20.6.
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1-Pyrrolidin-l-yl-butane-l, 3-dione 95
A two-necked, 100-mL round-bottomed flask equipped with a reflux condenser and 
magnetic stir-bar was charged with 30 mL of deionized water, sodium bicarbonate (2.52 
g, 30.0 mmol) and pyrrolidine (1.7 mL, 20.0 mmol). Diketene (2.3 mL, 30.0 mmol) was 
added to the flask dropwise. The reaction mixture was allowed to heat to 50 °C in water 
bath, and stirred for 2 h. The reaction was stirred at room temperature overnight, then 
quenched with 10 mL o f saturated citric acid solution, extracted with ethyl acetate (3><20 
mL). The combined organic layers were washed with saturated sodium bicarbonate 
solution (2 x 1 0  ml), and brine (3x15 ml), dried over anhydrous sodium sulfate, filtered, 
and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica (ethyl acetate, R/ = 0.51) to yield 0.62 g (20%) of
1-pyrrolidin-l-yl-butane-1,3-dione 95 as a clear orange liquid. Enol form was also 
present. *H NMR (400 MHz, CDC13) 8  3.49-3.40 (m, 6  H)), 2.29 (s, 3 H), 2.00-1.85 (m, 4 
H); enol form: 8  4.99 (s, 1H), 3.49-3.40 (m, 4 H)), 1.95 (s, 3 H), 2.00-1.85 (m, 4 H); 13C 
NMR (100 MHz, CDC13) 8  202.6, 165.1, 51.5, 47.3, 45.9, 30.5, 26.1, 24.6, enol form: 8
174.2, 170.4, 88.9, 46.2, 45.0, 26.0, 21.7. IR (neat, cm '1): 2975, 2880, 1717, 1626, 1454, 
1361.
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4. Preparation of a chiral P-Keto imide
l-((5) 4-Benzyl-2-oxo-oxazolidin-3-yl)-butane-l, 3-dione 112
An oven-dried, one-necked, 100-mL round-bottomed flask equipped with a rubber 
septum and magnetic stir-bar was cooled to room temperature under a nitrogen 
atmosphere, and charged with a solution o f (S)-4-benzyl-oxazolidin-2-one (1.4 g, 8.0 
mmol) in 50 mL of anhydrous tetrahydrofuran. The THF solution was cooled to -78 °C 
and n-butyl lithium (4.0 mL, 10.0 mmol o f a 2.5 M solution in hexane) was added 
dropwise to the flask. After the completion o f the addition, the reaction mixture was 
warmed to 0 °C for 10 min. The mixture was cooled to -78 °C again, and diketene (1.23 
mL, 16.0 mmol) was added slowly to the mixture. The resultant orange solution was 
maintained at -78 °C for an additional 30 min after the addition was complete, and then 
allowed to stir at 0 °C for 2 h. The mixture was quenched with 15 mL of saturated NH4CI 
solution and concentrated under reduced pressure (25 °C, 18 torr) to remove the solvent 
THF. The residue was extracted by methylene chloride (3><20 mL), and the combined 
organic layers were washed with sat. NaHCC>3 solution (2x20 mL) and brine (3x20 mL), 
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. 
The residue was purified by column chromatography on silica (4:1, hexane: ethyl acetate, 
R/ = 0.14) to yield 0.80 g (38%) of 1-((*S) 4-benzyl-2-oxo
-oxazolidin-3-yl)-butane-l,3-dione 112 as a light yellow solid, mp 67-68.5 °C; 'H NMR 
(400 MHz, CDCI3) 5 7.36-7.22 (m, 5 H), 4.72 (m, 1 H), 4.25-4.16 (m, 2 H ), 4.11-4.06 
(m, 2 H), 3.37 (dd, J  = 3.4, 13.5 Hz, 1 H), 2.80 (dd, 7  = 9.6, 13.5 Hz, 1 H), 2.29 (s, 3 H);
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13C NMR (100 MHz, CDC13) S 201.1, 166.6, 153.9, 135.3, 129.7, 129.2, 127.6, 6 6 .6 ,
55.2, 51.6, 38.4, 30.4; enol form: 5 180.5, 153.9, 135.3, 129.7, 129.2, 127.6, 90.1, 66.3,
54.9,38.4,22.4.
5. Preparation of a-Iodomethyl y-Keto Imides
2-Iodomethyl-l-(2-oxo-oxazolidin-3-yl)-pentane-l, 4-dione 102
An oven-dried, one-necked, 100-mL round-bottomed flask equipped with a rubber 
septum and magnetic stir-bar was cooled to room temperature under a nitrogen 
atmosphere, and charged with l-(2-oxo-oxazolidin-3-yl)-butane-l,3-dione (0.346 g, 2.0 
mmol) dissolved in 30 mL of methylene chloride. The solvent was cooled to 0 °C in an 
ice bath and diethyl zinc (10.0 mL, 1.0 M in hexane, 10.0 mmol) was added slowly to the 
flask at 0 °C over two min to form an enolate. The reaction mixture was stirred for 15 
min, and then methylene iodide (0.48 mL, 6.0 mmol) was added into the flask. An 
additional portion of methylene iodide (0.32 mL, 4.0 mmol) was added to the reaction 
mixture at 0 °C after 15 to 20 min. The resulting solution was stirred for 30 min, and 
trimethylsilylchloride (50 pL, 0.4 mmol) was added by micro-syringe in one portion. The 
mixture was allowed to stir for 30 min at room temperature followed by the addition of 
iodine (2.58 g, 10.0 mmol) to the reaction mixture. The reaction mixture quickly became 
a pink suspension and was stirred for 10 min, quenched with 10 mL of saturated aqueous 
ammonium chloride, and extracted with ether acetate (5x20 mL). The combined organic 
layers were washed with saturated sodium thiosulfate solution (2x25 mL), and brine
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(3x25 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure (25 °C, 20 torr). The residue was purified by column chromatography 
on silica (2:1, hexane: ethyl acetate, R/ -  0.16) to yield 0.101 g (31%) o f
2-iodomethyl-l-(2-oxo- oxazolidin-3-yl)-pentane-l,4-dione 102 as a yellow solid, mp 
71-75 °C; !H NMR (400 MHz, CDC13) 5 4.50-4.42 (m, 2 H), 4.31 (m, 1 H), 4.12-3.97 (m, 
2H), 3.39 (dd, J =  5.4, 10.2 Hz, 1H), 3.32 (dd, J =  6.5, 10.1 Hz, 1H), 3.16 (dd, J  = 9.9,
18.1 Hz, 1H), 2.75 (dd, J =  4.1, 18.0 Hz, 1H), 2.18 (s, 3H); 13C NMR (100 MHz, CDCI3) 
5 206.1, 172.3, 153.4, 62.4, 46.6, 42.9, 39.0, 29.9, 4.4.
3-[l-Hydroxy-2-(2-oxo-propyl)-cyclopropyl]-oxazolidin-2-one 107 and 2-Methyl-l- 
(2-oxo-oxazolidin-3-yl)-pentane-l, 4-dione 108
An oven-dried, one-necked, 100-mL round-bottomed flask equipped with a rubber 
septum and magnetic stir-bar was cooled to room temperature under a nitrogen 
atmosphere, and charged with l-(2-oxo-oxazolidin-3-yl)-butane-l,3-dione (0.171 g, 1 
mmol) dissolved in 15 mL of methylene chloride. The solvent was cooled to 0 °C in an 
ice bath and diethyl zinc (5.0 mL, 1.0 M in hexane, 5.0 mmol) was added slowly to the 
flask at 0 °C over two min to form an enolate. The reaction mixture was stirred for 15 
min, and then methylene iodide (0.24 mL, 3.0 mmol) was added into the flask. An 
additional portion o f methylene iodide (0.16 mL, 2.0 mmol) was added to the reaction 
mixture at 0 °C after 15 to 20 min. The resulting solution was stirred for 30 min, and 
trimethylsilylchloride (50 pL, 0.4 mmol) was added by micro-syringe in one portion. The
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mixture was allowed to stir for 45 min, quenched with 10 mL of saturated aqueous 
ammonium chloride, and extracted with ether acetate (3x20 mL). The combined organic 
layers was washed with brine (3x15 mL), dried over anhydrous sodium sulfate, filtered, 
and concentrated under reduced pressure (25 °C, 20 torr). The residue was purified by 
column chromatography on silica (2:1, hexane: ethyl acetate, R/ = 0.08) to yield 0.06 g 
(30%) of 3-[l-hydroxy-2-(2-oxo-propyl)-cyclopropyl]-oxazolidin-2-one 107 as a 
colorless liquid. ]H NMR (400 MHz, CDC13) 8  4.28-4.16 (m, 2 H), 3.76-3.66 (m, 2 H), 
2.56 (dd, J =  4.1,17.4 Hz, 1 H ), 2.35 (dd, 8.8,18.2 Hz, 1 H), 2.09 (s, 3 H), 1.64-1.59 
(m, 2 H), 1.18 (m, 1 H), 0.78 (t, J =  6.9 Hz, 1 H); 13C NMR (100 MHz, CDC13) 8  209.1,
158.2, 65.2, 62.8, 43.4, 42.3, 30.3, 20.9, 20.5; IR (neat, cm '1): 3442(b), 2927, 1775, 1699, 
1390, 1227, 1039.
A compound 2-methyl-l-(2-oxo-oxazolidin-3-yl)-pentane-l, 4-dione 108 was also 
isolated from the crude reaction mixture by column chromatography on silica (2 :1 , 
hexane: ethyl acetate, R/ = 0.16) in a 22% yield (0.043 g) as a colorless liquid. *H NMR 
(400 MHz, CDC13) 8  4.43-4.30 (m, 2 H), 4.41-3.95 (m, 3 H), 3.10 (dd, J =  10.3, 18.1 Hz, 
1 H), 2.53 (dd, J  = 4.1, 18.2, 1 H), 2.14 (s, 3 H), 1.18 (d, J =  7.0 Hz, 3 H); 13C NMR (100 
MHz, CDC13) 8  207.1, 176.8, 153.4, 62.2, 47.4, 42.9, 33.3, 29.8, 17.3. IR (neat, cm '1): 
1775, 1698, 1392, 1264,1202.
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l-((.S)-4-Benzyl-2-oxo-oxazolidin-3-yl)-2-iodomethyl-pentane-l, 4-dione 113 and 
(5)-4-Benzyl-3-[l-hydroxy-2-(2-oxo-propyI)-cyclopropyl]-oxazolidin-2-one 114
An oven-dried, one-necked, 50-mL round-bottomed flask equipped with a rubber 
septum and magnetic stir-bar was cooled to room temperature under a nitrogen 
atmosphere, and charged with a solution o f 1 -((5) 4-benzyl-2-oxo-oxazolidin-3-yl) 
-butane-1,3-dione 112 ( 0.261 g, 1.0 mmol) in 15 mL of methylene chloride. The solvent 
is cooled to 0 °C in an ice bath and diethyl zinc (5.0 mL, 1.0 M in hexane, 5.0 mmol) was 
added slowly to the flask at 0 °C over two min to form an enolate. The reaction mixture 
was stirred for 15 min, and then methylene iodide (0.24 mL, 3.0 mmol) was added into 
the flask. An additional portion o f methylene iodide (0.16 mL, 2.0 mmol) was added to 
the mixture at 0 °C after 15 to 20 min. The resultant solution was stirred for 30 min, and 
trimethylsilylchloride (25 pL, 0.2 mmol) was added by micro-syringe in one portion. The 
mixture was allowed to stir for 30 min at room temperature followed by adding iodine 
(1.265 g, 5.0 mmol) to the reaction. The reaction mixture quickly became a pink 
suspension and was stirred for 10 min, quenched with 10 mL o f saturated aqueous 
ammonium chloride, and extracted with ether acetate (3x20 mL). The combined organic 
layers were washed with saturated sodium thiosulfate solution (2x15 mL) and brine 
(3x15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure. The residue was purified by column chromatography on silica (3:1, 
hexane: ethyl acetate, R/ = 0.28) to yield 0.11 g (26%) of
l-((5)-4-Benzyl-2-oxo-oxazolidin-3-yl)-2-iodomethyl -pentane-1,4-dione 113 as a light
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yellow liquid o f two diastereoisomers with a ratio o f 2.5:1. *H NMR (400 MHz, CDCI3) 8  
7.33-7.20 (m, 5 H), 4.80-4.67 (m, 1 H), 4.31-4.16 (m, 3 H), 3.42 (d, J =  5.5 Hz, 2 H), 
3.36-3.33 (m, 1 H), 3.20 (dd, J  = 10.1, 18.1 Hz, 1 H), 2.87-2.69 (m, 2 H), 2.19 (s, 3 H); 
13C NMR (100 MHz, CDCI3) 8  206.0, 172.0, 153.3, 140.9, 129.6, 129.2, 127.7, 6 6 .8 ,
55.5, 46.4, 40.0, 38.5, 37.8, 29.9, 4.9; MS (MALDI): calcd for C i6H i80 4N I (M+-I) 
288.2782: found, 287.7.
The compound l-((5)-4-Benzyl-2-oxo-oxazolidin-3-yl)-pent-2-ene-l,4-dione was 
also present in the reaction mixture. Resonances observed for this compound: 'H  NMR 
(400 MHz, CDCI3) 8  8.0 (d, J =  15.9 Hz, 1 H), 7.1 (d, 15.9 Hz, 1 H); 13C NMR (100
MHz, CDCI3) 8  198.1, 164.4, 135.1, 27.8.
The crude reaction mixture was also purified by column chromatography on silica 
(1:1, hexane: ethyl acetate, R /=  0.12) to produce 0.08 g (28%) o f one predominant 
stereoisomer of (5)-4-Benzyl-3-[l-hydroxy-2-(2-oxo-propyl)-cyclopropyl]-oxazolidin-2- 
one 114 as a colorless crystal, mp 102-103 °C; [a]25o = +4.8 (c = 0.0053 g/mL, CHCI3). 
JH NMR (400 MHz, CDCI3) 8  7.39-7.25 (m, 5 H), 4.75 (s, 1 H), 4.22 (m, 1 H), 4.07-3.98 
(m, 2 H), 3.54 (d d ,J= 3 .8 , 13.4 Hz, 1H),2.83 ( d d ,J = 4 .5 ,18.4 Hz, 1 H), 2.71-2.62 (m, 2 
H), 2.22 (s, 3 H), 1.54 (m, 1 H), 1.38 (dd, J  -  5.9, 10.1 Hz, 1 H), 0.96 (t, J =  6.2 Hz, 1 H); 
,3C NMR (100 MHz, CDCI3) 8  208.5, 157.8, 136.7, 129.7, 129.2, 127.1, 66.9, 64.8, 57.6,
42.1, 38.4, 30.2, 21.8, 19.6. IR (KBr, cm'1): 3317 (b), 3029, 2921, 1745, 1603, 1413, 
1246. MS (MALDI): calcd for C 16Hi90 4N (M+ +Na+) 312.1871: found, 312.1; calcd for 
C]6Hi9 0 4N (M+ +K+) 328.3000: found, 328.1.
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6. Preparation of a-Alkylated y-Keto Esters 
2-Benzyl-5, 5-dimethyl-4-oxo-hexanoic acid methyl ester 115
A mixture o f zinc dust (0.09 g, 1.4 mmol) and iodine (2.0 mg, 0.005 mmol) was 
placed into an oven-dried, 25-mL round-bottomed flask equipped with a rubber septum 
and magnetic stir bar. The flask was allowed to cool to room temperature under nitrogen 
gas. Dimethylformamide (1 mL) was added via syringe into the flask, followed by the 
addition o f a solution o f iodobenzene (0.224 g, 1.1 mmol) in 4 mL o f DMF dropwise by 
syringe. The reaction mixture was stirred at 0 °C (ice bath) for 30 min. The ice bath was 
removed and the septum was replaced with a reflux condenser after 2-iodomethyl-5, 
S-dimethyl-4-oxo-hexanoic acid methyl ester 82 (0.312 g, 1.0 mmol),
tris(dibenzylideneaeetone)dipalladium(0) (45 mg, 0.05 mmol) and tri-o-tolylphosphine 
(60 mg, 0.2 mmol) were added. The reaction mixture was heated to 60 °C and stirred for 
5 h. The resulting black mixture was decanted to an Erlenmeyer flask containing 10 mL 
of deionized water. An additional 5 mL of saturated citric acid solution was added in 
order to break the emulsion. The mixture was extracted with diethyl ether (3x10 mL), and 
the combined organic layers were washed with deionized water (2x10 mL) and brine 
(2x10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure. The residue was purified by column chromatography (30:1, hexane: 
ethyl acetate, R/= 0.14) to yield 0.79 g (30%) o f 2-benzyl-5,5 -dimethyl-4-oxo-hexanoic 
acid methyl ester 115 as a clear orange liquid. 'H NMR (400 MHz, CDCI3) 8 7.26 (t, J  =
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7.4 Hz, 2 H), 7.19 (t, J =  7.3 Hz, 1 H), 7.13 (d, J =  6 . 8  Hz, 2H), 3.61 (s, 3 H), 3.14 (m, 
1H), 2.99 (dd, J =  6 .6 , 13.5 Hz, 1 H), 2.92 (dd, J =  9.0, 18.2 Hz, 1 H), 2.72 (dd, J =  8.3, 
13.6 Hz, 1 H), 2.56 (dd, J  = 4.6, 18.1 Hz, 1 H), 1.08 (s, 9 H); 13C NMR (100 MHz, 
CDCI3) 6  214.3, 175.6, 138.8, 129.4, 129.1, 126.8, 51.9, 44.1, 42.2, 37.9, 26.6; IR (neat, 
cm '1): 2966, 1736, 1704, 1476, 1366, 1230; MS (ESI): calcd for C 16H22O3 (M+ +Na+) 
285.1919: found, 285.1.
2-(4-Chloro-benzyl)-5, 5-dimethyl-4-oxo-hexanoic acid methyl ester 116
A mixture o f zinc dust (0.09 g, 1.4mmol) and iodine (2.0 mg, 0.005 mmol) was 
placed into an oven-dried, 25-mL round-bottomed flask equipped with a rubber septum 
and magnetic stir bar. The flask was allowed to cool to room temperature under nitrogen 
gas. Dimethylformamide (1 mL) was added via syringe into the flask followed by 
dropwise addition o f a solution o f 1-chloro-4-iodobenzene (0.3.0 g, 1.26 mmol) in 4 mL 
of DMF. The reaction mixture was stirred at 0 °C (ice bath) for 30 min. The ice bath was 
removed and the septum was replaced with a reflux condenser after 2-iodomethyl-5, 
5-dimethyl-4-oxo-hexanoic acid methyl ester 82 (0.312 g, 1.0 mmol),
tris(dibenzylideneacetone)dipalladium(0) (45.0 mg, 0.05 mmol) and 
tri-o-tolylphosphine (60 mg, 0.2 mmol) were added. The reaction mixture was heated to 
60 °C and stirred for 5 h. The resulting black mixture was decanted to an Erlenmeyer 
flask containing 10 mL o f deionized water. An additional 5 mL of saturated citric acid 
solution was added in order to break the emulsion. The mixture was extracted with
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diethyl ether (3x10 mL), and the combined organic layers were washed with deionized 
water (2x10 mL) and brine (2x10 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The residue was purified by column 
chromatography (20:1, hexane: ethyl acetate, R /=  0.18) to yield 0.075 g (25%) o f
2-(4-chloro-benzyl)-5,5 -dimethyl- 4-oxo-hexanoic acid methyl ester 116 as a clear 
orange liquid. 'H  NMR (400 MHz, CDC13) .8 7.25 (d, J =  8 . 6  Hz, 2 H), 7.09 (d, J =  8.3 
Hz, 2 H), 3.62 (s, 3 H), 3.15 (m, 1 H), 2.96 (dd, J =  7.0, 11.9 Hz, 1 H), 2.92 (dd, J =  8.5,
18.0 Hz, 1 H), 2.71 (dd, 7.8, 13.8 Hz, 1 H), 2.54 (dd, J = 4 .9 , 18.1 Hz, 1 H), 1.09 (s, 9 
H); 13C NMR (100 MHz, CDC13) 8  214.0, 175.6, 137.3, 132.6, 130.5, 128.8, 52.1, 44.3,
42.2, 38.5, 36.6, 26.6; IR (neat, cm '1): 2967, 1736, 1704, 1492, 1169.
fer#-Butyl-(4-iodo-phenoxyl)-dimethyl-silane 117
Into an oven-dried, 50-mL round-bottomed flask purged under N2 and equipped 
with a rubber septum and magnetic stir bar were placed iodophenol (1.1 g, 5.0 mmol), 
t-butyldimethylsilyl chloride (1.2 g, 7.5 mmol) and 12 mL of pyridine. The reaction 
mixture was heated to 45 °C (water bath) and stirred for 4 h. The resultant solution was 
extracted by diethyl ether (3x15 mL) and neutralized by IN HC1 solution (2x10 mL), 
then washed with brine (3X20 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The crude residue was purified by column 
chromatography using pure ether acetate as the mobile phase (R/ = 0.8) to yield 0.73 g 
(44%) o f tert-butyl-(4-iodo-phenoxyl)-dimethyl-silane as a colorless liquid. 'H NMR
71
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(400 MHz, CDCI3) 8  7.32 (d, J =  8 . 6  Hz, 2 H), 6.42 (d, J =  8 . 6  Hz, 2 H); 0.86 (s, 9 H), 
0.07 (s, 6  H); 13C NMR (100 MHz, CDCI3) 8  160.1, 142.75, 126.9, 88.1, 30.1, 22.7, 0.0. 
Acetic acid 4-iodo-phenyl ester 118
Into an oven-dried, 50-mL round-bottomed flask purged under N2 and equipped with 
a rubber septum and magnetic stir bar were placed iodophenol (1.1 g, 5.0 mmol), acetic 
anhydride (0.7 mL, 7.5 mmol) and 10 mL of pyridine. The reaction mixture was allowed 
to stir at room temperature for 12 h. The resultant solution was extracted by diethyl ether 
(3x20 mL). The combined ether layers were washed with brine (3x15 mL) and 
neutralized by IN HC1 solution (2x10 mL), then washed with brine (2x15 mL) again, 
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. 
The crude residue was purified by column chromatography (20:1, hexane: ethyl acetate, 
R/ = 0.25) to yield 1.14 g (87%) o f acetic acid 4-iodo-phenyl ester as a white solid. Mp 
36-38 °C; *H NMR (400 MHz, CDC13) 8  7.68 (d, J =  8.7 Hz, 2 H), 6 . 8 6  (d, J  = 8.7 Hz, 2 
H), 2.28 (s, 3 H); 13C NMR (100 MHz, CDC13) 8  169.2, 150.7, 138.8, 124.0, 90.1, 21.3; 
IR (KBr, cm'1): 3083, 2264, 1980, 1758, 1577, 1479, 1368.
2-Benzyl-l-(2-oxo-oxazolidin-3-yl)-pentane-l, 4-dione 121
A mixture o f zinc dust (0.09 g, 1.4 mmol) and iodine (2.0 mg, 0.005 mmol) was 
placed into an oven-dried, 25-mL round-bottomed flask equipped with a rubber septum 
and magnetic stir bar. The flask was allowed to cool to room temperature under nitrogen 
gas. Dimethylformamide (1 mL) was added via syringe into the flask followed by the
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dropwise addition of a solution of iodobenzene (0.224 g, 1.1 mmol) in 4 mL of DMF. 
The reaction mixture was stirred at 0 °C (ice bath) for 30 min. The ice bath was removed 
and the septum was replaced with a reflux condenser after 2 -iodomethyl-l- 
(2-oxo-oxazolidin-3-yl)-pentane-l, 4-dione 102 (0.325 g, 1.0 mmol),
tris(dibenzylideneacetone)dipalladium(0) (45 mg, 0.05 mmol) and tri-o-tolyl phosphine 
(60 mg, 0.2 mmol) were added. The reaction mixture was heated to 60 °C and stirred for 
5 h. The resulting black mixture was decanted to an Erlenmeyer flask containing 10 mL 
of deionized water. An additional 5 mL of saturated citric acid solution was added in 
order to break the emulsion. The mixture was extracted with ether acetate (3x10 mL), and 
the combined organic layers were washed with deionized water (2x10 mL) and brine 
(2x10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure. The residue was purified by column chromatography (1:1, hexane: 
ethyl acetate, R/ = 0.47) to yield 0.066 g (24%) o f 2-benzyl-l-(2-oxo-oxazolidin 
-3-yl)-pentane- 1,4-dione 121 as a white solid, mp 108-111 °C; VH NMR (400 MHz, 
CDC13) 6  7.30-7.27 (m, 5 H), 4.45-4.30 (m, 3 H); 4.05 (dd, 7  = 6.7, 9.4 Hz, 1 H), 3.93 
(dd, J  = 6.9, 9.3 Hz, 1 H), 3.09 (dd, 7  = 5.1, 13.1 Hz, 1 H), 3.03 (dd, 7  = 10.7, 18.0 Hz, 1 
H), 2.51 (dd, 7 =  10.0, 13.1 Hz, 1 H), 2.45 (dd, 7 =  3.5, 18.3 Hz, 1 H), 2.07 (s, 3 H); I3C 
NMR (100 MHz, CDCI3) 6  207.2, 175.7, 153.4, 138.2, 129.4, 128.7, 126.9, 62.2, 44.4, 
42.9, 40.2, 37.9, 29.9. IR (KBr, cm '1): 2921, 1773, 1715, 1480, 1395, 1263.
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5 .5-Dimethyl-2-(2-methyl-allyl)-4-oxo-hexanoic acid methyl ester 122
A mixture o f zinc dust (0.09 g, 1.4 mmol) and iodine (2.0 mg, 0.005 mmol) was 
placed into an oven-dried, 25-mL round-bottomed flask equipped with a rubber septum 
and magnetic stir bar. The flask was allowed to cool to room temperature under nitrogen 
gas. Dimethylformamide (1 mL) was added via syringe into the flask followed by the 
dropwise addition o f a solution o f 2-bromo-l-propene (0.30 g, 1.26 mmol) in 4 mL of 
DMF. The reaction mixture was stirred at 0 °C (ice bath) for 30 min. The ice bath was 
removed and the septum was replaced with a reflux condenser after 2-iodomethyl-5, 
5-dimethyl-4-oxo-hexanoic acid methyl ester 82 (0.312 g, 1.0 mmol),
tris(dibenzylideneacetone)dipalladium(0) (45 mg, 0.05 mmol) and tri-o-tolylphosphine 
(60 mg, 0.2 mmol) were added. The reaction mixture was heated to 60 °C and stirred for 
5 h. The resulting black mixture was decanted to a Erlenmeyer flask containing 10 mL of 
deionized water. An additional 5 mL o f saturated citric acid solution was added in order 
to break the emulsion. The mixture was extracted with diethyl ether (3x10 mL), and the 
combined organic layers were washed with deionized water (2x10 mL) and brine (2x10 
mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced 
pressure. The residue was purified by column chromatography (20:1, hexane: ethyl 
acetate, R/ = 0.15) to yield 0.075 g (12%) of
5.5-dimethyl-2-(2-methyl-allyl)-4-oxo-hexanoic acid methyl ester 122 as a clear orange 
liquid. *H NMR (400 MHz, CDC13) 5 4.79 (s, 1 H), 4.69 (s, 1 H), 3.66 (s, 3 H), 3.07 (m, 1 
H), 2.92 (dd, J =  9.3, 18.1 Hz, 1 H), 2.58 (dd, J  = 4.2, 18.1 Hz, 1 H), 2.38 (dd, J =  6 .8 ,
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14.2 Hz, 1 H), 2.14 (dd, 7 =  8.5, 14.6 Hz, 1 H), 1.79 (s, 3 H), 1.14 (s, 9 H); 13C NMR 
(100 MHz, CDC13) 8  214.4,175.9,142.8, 113.2,51.9,44.2,40.5,38.4,38.1,26.5,21.9.
7. Preparation of Compound 124 
(5)-2-(4-Methoxy-benzylamino)-3-methyl-butyric acid 126
To a 250-mL round-bottomed flask containing a solution o f L-valine (12.42 g, 106 
mmol) in 50 mL of 2.0 M NaOH was added p-anisaldehyde (12.7 mL, 104.0 mmol) in 
one portion. The reaction mixture was allowed to stir at room temperature for 30 min, 
cooled to 0 °C and sodium borohydride (1.6 g, 42.0 mmol) was added in small portion. 
After an additional 30 min, a second portion o f />anisaldehyde (6 . 8  mL, 56.0 mmol) was 
added into the mixture and kept stirring for 1 h, then a second portion o f sodium 
borohydride (1.6 g, 42.0 mmol) was added and after 4 h the mixture was neutralized with 
1 N HC1 to PH 6 . The resulting white precipitate was collected by filtration, washed with 
cold water and air-dried for 2 h. The solid was dissolved in 100 mL o f 1 M NaOH and 
extracted with diethyl ether (2^50 mL). The aqueous layer was neutralized with 1 N HC1 
to PH 6 . The resulting white solid was collected by filtration and dried under reduced 
pressure to yield 14.6 g (58%) o f (5)-2-(4-methoxy-benzylamino)- 3-methyl-butyric acid 
126 as a white powder, mp 244-247 °C; !H NMR (400 MHz, DMSO-d6/TFA) 8  7.42 (d, J  
= 8 . 8  Hz, 2 H), 7.00 (d, J  = 8 . 8  Hz, 2 H), 4.12 (s, 2 H), 3.78 (s, 3 H), 3.72 (s, 1 H), 
2.32-2.27 (m, 1 H), 1.03 (d, J =  7.0 Hz, 3 H), 0.94 (d, J =  6.9 Hz, 3 H); 13C NMR (100
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MHz, DMSO-d6/TFA) 8 169.7, 159.6, 132.7, 123.5, 117.5, 64.3, 54.9, 50.4, 29.1, 18.9,
18.8;IR(KBr, cm'1): 3447(b), 2962, 1602, 1515, 1454, 1322, 1254, 1221, 1177.
(iS )-2- [Benzyloxycarbonyl-(4-methoxy-benzyl)-amiiio] -3-methyl-butyric acid 127
Pmb-protected L-valine 126 (1.19 g, 5.0 mmol) was dissolved in the 20 mL o f 1 N 
NaOH and 20 mL o f THF. The mixture was kept stirring at room temperature for 30 min, 
then cooled to 0 °C and benzyloxycarbonyl chloride (0.69 mL, 5.0 mmol) was added in 
one portion. The reaction was vigorously stirred overnight. The resulting mixture was 
washed with ether (2x15 mL) and acidified with conc. HC1 to pH 1. The resulting cloudy 
solution was extracted with ethyl acetate (3x20 mL). The combined organic layers were 
washed with brine (2x15 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure to yield 0.93 g (50%) o f compound 127 as a light 
yellow oily liquid. The compound exists as a mixture o f 2 rotameric forms. 1 H NMR (400 
MHz, CDC13) 8  10.0 (bs, 1 H), 7.37-6.77 (m, 9 H), 5.17 (s, 2 H), 4.53-4.44 (m, 2 H), 3.99 
(m, 1 H), 3.72 (s, 3 H), 2.42-2.26 (m, 1 H), 1.01-0.68 (m, 6  H); 13C NMR (100 MHz, 
CDCI3) 8  176.2, 174.6, 159.1, 157.7, 136.4, 130.4, 130.1, 129.4, 128.7, 128.5, 128.4,
128.2, 113.9, 68.3, 68.1, 65.4, 55.4, 50.8, 27.9, 20.4, 19.6; IR (neat, cm '1): 3500-2837 (b), 
2964, 1736, 1700, 1613, 1513, 1458, 1247.
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[4-((/?)-4-Benzyl-2-oxo-oxazolidin-3-yl)-(S)-l-isopropyl-2,
4-dioxo-butyl]-(4-methoxy-benzyI)-carbamic acid benzyl ester 129
An oven-dried, 10-mL round-bottomed flask equipped with a rubber septum and 
magnetic stir-bar was purged under nitrogen, and charged with 4 mL o f anhydrous 
tetrahydrofuran, compound 127 ( 0.381 g, 1.0 mmol, in 1 mL of anhydrous THF), and 
1,1-carbonyldiimidazole (0.18 g, 1.1 mmol) in order. In a separate oven-dried, 50-mL 
round-bottomed flask, equipped with a rubber septum and magnetic stir-bar under 
nitrogen, were charged with 15 mL of anhydrous tetrahydrofuran and diisopropylamine 
(0.57 mL, 4.0 mmol). The solution was allowed to cool to 0 °C (ice bath) and «-butyl 
lithium (1.9 mL, 4.0 mmol, 2.1 M in hexane solution) was added. After stirring for 10 
min, the reaction mixture was cooled to -78 °C (dry ice in acetone bath), 
(/?)-3-acetyl-5-benzyl oxazolidin-2-one (0.88 g, 4.0 mmol, in 5 mL of anhydrous THF) 
was added over 30 min using a syringe pump. The acyl imidazole solution was 
transferred to the 50-mL flask containing the enolate solution using syringe quickly. The 
reaction was quenched with 5 mL o f IN HC1 solution after stirring at -78 °C for 30 min. 
The solution was extracted with diethyl ether (3x10 mL), and the combine ether layers 
were washed with 10 mL of sat.NaHCC>3 solution to remove the acid. The organic layer 
was washed with 5 mL of brine, dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The residue was purified by column 
chromatography (3:1, hexane: ethyl acetate, R/ = 0.28) to yield 0.337 g (59%) of 
compound 129 as a light yellow oily mixture. [a]25o = -85.0 (c = 0.006 g/mL, CHCI3); *H
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NMR (400 MHz, CDC13) 5 7.32-7.03 (m, 12 H), 6.79-6.69 (m, 2 H), 5.17-5.04 (m, 2 H), 
4.73-4.49 (m, 2 H), 4.18-4.00 (m, 4 H), 3.89-3.60 (m, 1 H), 3.70-3.69 (m, 3 H), 3.29-3.20 
(m, 1 H), 2.72-2.63 (m, 1 H), 2.38-2.23 (m, 1 H), 0.93-0.80 (m, 3H), 0.72-0.64 (m, 3 H); 
13C NMR (100 MHz, CDCI3) 6  200.2, 166.8, 159.5, 156.5, 153.5, 136.4, 135.5, 131.1,
130.4, 129.7, 129.2, 128.8, 128.4, 127.5, 114.1, 71.1, 68.1, 66.4, 55.5, 55.2, 49.9, 49.1,
48.6, 37.5, 27.3, 26.7, 21.6, 20.8, 19.1; IR (neat, cm '1): 3029, 2962, 1779, 1697, 1611, 
1512, 1454, 1359, 1247; MS (ESI): calcd for C33H36O7N2 (M+ +Na+) 596.3569: found,
595.1.
[5-((/?)-4-Benzyl-2-oxo-oxazolidin-3-yl)-4-iodomethyl-(5)-l-isopropyl-2, 
5-dioxo-pentyl]-(4-methoxy-benzyl)-carbamic acid benzyl ester 130
An oven-dried, one-necked, 100-mL round-bottomed flask equipped with a rubber 
septum and magnetic stir-bar with a flow o f nitrogen was cooled to room temperature, 
and charged with compound 129 ( 0.26 g, 0.45 mmol) dissolved in 8  mL o f methylene 
chloride. The solvent was cooled to 0 °C in an ice bath and diethyl zinc (2.3 mL, 1.0 M in 
hexane, 2.3 mmol) was added slowly to the flask at 0 °C over 1 min to form an enolate. 
The reaction mixture was stirred for 15 min, and then methylene iodide (0.11 mL, 1.38 
mmol) was added into the flask. An additional portion of methylene iodide (0.07 mL, 
0.87 mmol) was added to the reaction mixture at 0 °C after 30 min. The resulting solution 
was stirred for 30 min, and trimethylsilylchloride (12.5 pL, 0.2 mmol) was added by 
micro-syringe in one portion. The mixture was allowed to stir for 1 h at 0 °C followed by
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the addition o f iodine (0.57 g, 2.25 mmol) to the reaction. The reaction mixture quickly 
became a pink suspension and stirred for 10 min, quenched with 5 mL of saturated 
aqueous ammonium chloride, and extracted with ether acetate (3x15 mL). The combined 
organic layers were washed with saturated sodium thiosulfate solution (2x10 mL), and 
brine (3x15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure. The residue was purified by column chromatography on silica (5:1, 
hexane: ethyl acetate, R/ = 0.27) to yield 0.15 g (46%) o f compound 130 as a orange oily 
liquid. *H NMR (400 MHz, CDC13) 8  7.49-7.06 (m, 12 H), 6.86-6.76 (m, 25.5 Hz, 2 H), 
5.27-5.20 (m, 2 H), 4.70-4.59 (m, 1 H), 4.51-4.40 (m, 1 H), 4.28-4.11 (m, 4 H), 4.04-3.86 
(m, 1 H), 3.80 (s, 3 H), 3.34-3.25 (m, 1 H), 3.17-3.02 (m, 2 H), 2.89-2.69 (m, 2 H), 
2.60-2.33 (m, 2 H), 1.00-0.73 (m, 6  H); 13C NMR (100 MHz, CDC13) 8  205.4, 171.8,
159.4, 155.6, 153.8, 136.4, 135.4, 130.8, 129.9, 129.7, 129.3, 129.1, 128.8, 128.4, 127.6,
114.2, 69.3, 68.5, 66.5, 60.6, 58.1, 55.4, 48.2, 43.8, 38.4, 30.2, 26.2, 21.5, 19.6, 4.7; MS 
(ESI): calcd for C35H39O7 N21 (M+ +Na+) 749.5965: found, 749.1.




Into an oven-dried, one-necked, 25-mL round-bottomed flask equipped with a 
rubber septum and magnetic stir-bar with a flow of nitrogen were placed sodium sulfide
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Na2S (0.78 g, 10.0 mmol) and 9 mL o f N,  A^-dimethylform amide. The solution was for 20 
min at room temperature. The yellow suspension was allowed to cooled in a -15 °C ( dry 
ice in ethylene glycol) and compound 82 (0.312 g, 1.0 mmol, in 1 mL o f DMF) was 
added to the reaction mixture which was stirred for 5 h. The reaction was quenched with 
2 mL of sat. NH4CI solution. The DMF and water were removed under reduced pressure 
(50 °C, 18 torr). The residue was extracted with diethyl ether (3x15 mL) and the 
combined organic layers were washed with brine (3x15 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure. The residue was 
purified by column chromatography on silica (6:1, hexane: ethyl acetate, R/ = 0.09) to 
yield 0.09 g (25%) of compound 140 as a light yellow liquid. 'H NMR (400 MHz, 
CDCI3) 5 3.67 (s, 6  H), 3.11-3.04 (m, 2 H), 3.02-2.98 (m, 2 H), 2.85-2.75 (m, 4 H), 
2.67-2.61 (m, 2 H), 1.13 (s, 18 H); 13C NMR (100 MHz, CDCI3) 8  213.8, 174.3, 52.2,
44.2, 42.4, 37.7, 34.0, 26.6; IR (neat, cm '1): 2967, 1737, 1703, 1476, 1366, 1202. MS 
(MALDI): calcd for C2oH34 0 6S (M+ +Na+) 425.6160: found, 425.6.
2-Acetylsulfanylmethyl-5, 5-dimethyl-4-oxo-hexanoid acid methyl ester 142
Into an oven-dried, one-necked, 10-mL round-bottomed flask equipped with a rubber 
septum and magnetic stir-bar with a flow o f nitrogen were placed potassium thioacetate 
(0.23 g, 2.0 mmol), compound 82 (0.312 g, in 1 mL o f tetrahydrofuran, 1.0 mmol) and
4.0 mL of tetrahydrofuran. The light yellow suspension was allowed to stir overnight at 
room temperature. The resultant brown suspension was extracted with diethyl ether (3x15
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mL) and the organic layer was removed using a pipette. The combined ether extracts 
were washed with brine (3x15 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The residue was purified by column 
chromatography on silica (15:1, hexane: ethyl acetate, R/ =0.10) to yield 0.17 g (65%) 
o f 2-acetylsulfanylmethyl-5,5-dimethyl-4-oxo-hexanoid acid methyl ester 142 as a 
orange liquid. ’H NMR (400 MHz, CDC13) 5 3.63 (s, 3 H), 3.16 (dd, J =  8.0, 15.6 Hz, 1 
H), 3.08-3.02 (m, 2 H), 2.96 (dd, J =  7.2, 18.0 Hz, 1 H), 2.64 (dd, J  = 4.2, 17.8 Hz, 1 H), 
2.27 (s, 3 H), 1.08 (s, 9 H); 13C NMR (100 MHz, CDC13) 8  213.8, 194.9, 173.8, 52.3,
44.1, 40.3, 37.5, 30.5, 30.2, 26.6.
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